Publications

  1. Shin A, Camilleri M, Nadeau A, Nullens S, Rhee JC, Jeong ID, Burton DD. Interpretation of overall colonic transit in defecation disorders in males and females. Neurogastroenterol Motil. 2013 Jun; 25(6):502-8. Epub 2013 Feb 14. 2304035
    View PubMed
  2. Vijayvargiya P, Camilleri M, Shin A, Breen M, Burton D. Simplifying the measurement of gastric accommodation using SPECT. Neurogastroenterol Motil. 2013 Jun; 25(6):542-6. Epub 2013 Feb 17. 2304045
    View PubMed
  3. Camilleri M. Genetics of human gastrointestinal sensation. Neurogastroenterol Motil. 2013 Jun; 25(6):458-66. Epub 2013 Apr 17. 2317710
    View PubMed
  4. Camilleri M. Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome. Expert Opin Pharmacother. 2013 Jun; 14(9):1151-60. Epub 2013 Apr 27. 2319953
    View PubMed
  5. Camilleri M, Shin A. Novel and Validated Approaches for Gastric Emptying Scintigraphy in Patients with Suspected Gastroparesis. Dig Dis Sci. 2013 May 22. [Epub ahead of print] 2325673
    View PubMed
  6. Vijayvargiya P, Camilleri M, Shin A, Saenger A. Methods for Diagnosis of Bile Acid Malabsorption in Clinical Practice. Clin Gastroenterol Hepatol. 2013 May 02. [Epub ahead of print] 2321928
    View PubMed
  7. Bharucha AE, Low P, Camilleri M, Veil E, Burton D, Kudva Y, Shah P, Gehrking T, Zinsmeister AR. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013 May; 62(5):708-15. Epub 2012 Jun 07. 2252464
    View PubMed
  8. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, Marietta E, O'Neill J, Carlson P, Lamsam J, Janzow D, Eckert D, Burton D, Zinsmeister AR. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013 May; 144(5):903-911.e3. Epub 2013 Jan 25. 2299565
    View PubMed
  9. Iturrino J, Camilleri M, Wong BS, Linker Nord SJ, Burton D, Zinsmeister AR. Randomised clinical trial: the effects of daikenchuto, TU-100, on gastrointestinal and colonic transit, anorectal and bowel function in female patients with functional constipation. Aliment Pharmacol Ther. 2013 Apr; 37(8):776-85. Epub 2013 Mar 04. 2308259
    View PubMed
  10. Camilleri M, Kolar GJ, Vazquez-Roque MI, Carlson P, Burton DD, Zinsmeister AR. Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. Am J Physiol Gastrointest Liver Physiol. 2013 Mar 1; 304(5):G553-60. Epub 2013 Jan 10. 2308235
    View PubMed
  11. Camilleri M, Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013 Mar; 10(3):187-94. Epub 2013 Feb 05. 2301268
    View PubMed
  12. Zinsmeister AR, Burton D, Camilleri M. Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations. Dig Dis Sci. 2013 Feb; 58(2):509-18. Epub 2012 Aug 24. 2265976
    View PubMed
  13. Topazian M, Camilleri M, Enders FT, Clain JE, Gleeson FC, Levy MJ, Rajan E, Nehra V, Dierkhising RA, Collazo-Clavell ML, Talley NJ, Clark MM. Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):145-50.e1. Epub 2012 Oct 09. 2277550
    View PubMed
  14. Grover M, Camilleri M. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. J Gastroenterol. 2013 Feb; 48(2):177-81. Epub 2012 Dec 20. 2292273
    View PubMed
  15. Wong BS, Camilleri M. Elobixibat for the treatment of constipation. Expert Opin Investig Drugs. 2013 Feb; 22(2):277-84. Epub 2012 Dec 08. 2289349
    View PubMed
  16. Shin A, Camilleri M, Busciglio I, Burton D, Stoner E, Noonan P, Gottesdiener K, Smith SA, Vella A, Zinsmeister AR. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics. Diabetes Care. 2013 Jan; 36(1):41-8. Epub 2012 Sep 06. 2269142
    View PubMed
  17. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L, American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013 Jan; 108(1):18-37; quiz 38. Epub 2012 Nov 13. 2306756
    View PubMed
  18. Bharucha AE, Camilleri M, Veil E, Burton D, Zinsmeister AR. Comprehensive assessment of gastric emptying with a stable isotope breath test. Neurogastroenterol Motil. 2013 Jan; 25(1):e60-9. Epub 2012 Dec 06. 2289383
    View PubMed
  19. Schemann M, Camilleri M. Functions and imaging of mast cell and neural axis of the gut. Gastroenterology. 2013; 144(4):698-704.e4. 2316217
  20. Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, O'Neill J, Carlson P, Lamsam J, Eckert D, Janzow D, Burton D, Ryks M, Rhoten D, Zinsmeister AR. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2012 Dec 1; 303(11):G1262-9. Epub 2012 Oct 04. 2287746
    View PubMed
  21. Camilleri M, Iturrino J, Bharucha AE, Burton D, Shin A, Jeong ID, Zinsmeister AR. Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants. Neurogastroenterol Motil. 2012 Dec; 24(12):1076-e562. Epub 2012 Jul 02. 2256084
    View PubMed
  22. Zinsmeister AR, Bharucha AE, Camilleri M. Comparison of calculations to estimate gastric emptying half-time of solids in humans. Neurogastroenterol Motil. 2012 Dec; 24(12):1142-5. Epub 2012 Jul 20. 2259032
    View PubMed
  23. Camilleri M. Irritable bowel syndrome: how useful is the term and the 'diagnosis'? Therap Adv Gastroenterol. 2012 Nov; 5(6):381-6. 2283808
    View PubMed
  24. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012 Oct 25; 367(17):1626-35. 2284163
    View PubMed
  25. Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Oct; 303(7):G775-85. Epub 2012 Jul 26. 2273899
    View PubMed
  26. Katzka DA, Loftus EV Jr, Camilleri M. Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases. Clin Pharmacol Ther. 2012 Sep; 92(3):306-20. Epub 2012 Jul 25. 2259953
    View PubMed
  27. Wong BS, Camilleri M, Carlson P, McKinzie S, Busciglio I, Bondar O, Dyer RB, Lamsam J, Zinsmeister AR. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2012 Sep; 10(9):1009-15.e3. Epub 2012 May 18. 2247792
    View PubMed
  28. Nullens S, Nelsen T, Camilleri M, Burton D, Eckert D, Iturrino J, Vazquez-Roque M, Zinsmeister AR. Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation. Gut. 2012 Aug; 61(8):1132-9. Epub 2011 Dec 16. 2213744
    View PubMed
  29. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Sensations of gas and pain and their relationship with compliance during distension in human colon. Neurogastroenterol Motil. 2012 Jul; 24(7):646-51, e275. Epub 2012 Mar 06. 2230280
    View PubMed
  30. Camilleri M, Vazquez-Roque M, Iturrino J, Boldingh A, Burton D, McKinzie S, Wong BS, Rao AS, Kenny E, Mansson M, Zinsmeister AR. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 Jul; 303(1):G120-8. Epub 2012 Apr 19. 2256064
    View PubMed
  31. Camilleri M, Grover M, Farrugia G. What are the important subsets of gastroparesis? Neurogastroenterol Motil. 2012 Jul; 24(7):597-603. Epub 2012 May 24. 2247756
    View PubMed
  32. Kimpinski K, Iodice V, Burton DD, Camilleri M, Mullan BP, Lipp A, Sandroni P, Gehrking TL, Sletten DM, Ahlskog JE, Fealey RD, Singer W, Low PA. The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy. J Neurol Sci. 2012 Jun 15; 317(1-2):92-6. Epub 2012 Mar 14. 2234196
    View PubMed
  33. Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012 Jun; 24(6):503-12. 2281799
    View PubMed
  34. Money ME, Camilleri M. Review: Management of postprandial diarrhea syndrome. Am J Med. 2012 Jun; 125(6):538-44. 2253301
    View PubMed
  35. Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012 May 15; 302(10):G1075-84. Epub 2012 Mar 08. 2246671
    View PubMed
  36. Wong BS, Camilleri M, Carlson PJ, Odunsi-Shiyanbade S, McKinzie S, Busciglio I, Burton D, Zinsmeister AR. Pharmacogenetics of the effects of colesevelam on colonic transit in irritable bowel syndrome with diarrhea. Dig Dis Sci. 2012 May; 57(5):1222-6. Epub 2012 Jan 21. 2219711
    View PubMed
  37. Revicki DA, Camilleri M, Kuo B, Szarka LA, McCormack J, Parkman HP. Evaluating symptom outcomes in gastroparesis clinical trials: validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil. 2012 May; 24(5):456-63, e215-6. Epub 2012 Jan 27. 2220991
    View PubMed
  38. Tack J, Camilleri M, Chang L, Chey WD, Galligan JJ, Lacy BE, Muller-Lissner S, Quigley EM, Schuurkes J, De Maeyer JH, Stanghellini V. Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther. 2012 Apr; 35(7):745-67. Epub 2012 Feb 22. 2235829
    View PubMed
  39. Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D, Zinsmeister AR. Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil. 2012 Apr; 24(4):358-e169. Epub 2012 Jan 30. 2221029
    View PubMed
  40. Camilleri M, Di Lorenzo C. Brain-gut axis: from basic understanding to treatment of IBS and related disorders. J Pediatr Gastroenterol Nutr. 2012 Apr; 54(4):446-53. 2201899
    View PubMed
  41. Camilleri M, Tremaine WJ. Governance of clinical research. Am J Gastroenterol. 2012 Mar; 107(3):336-8. 2229020
    View PubMed
  42. Szarka LA, Camilleri M. Methods for the assessment of small-bowel and colonic transit. Semin Nucl Med. 2012 Mar; 42(2):113-23. 2221025
    View PubMed
  43. Camilleri M. The role of pharmacogenetics in nonmalignant gastrointestinal diseases. Nat Rev Gastroenterol Hepatol. 2012 Mar; 9(3):173-84. Epub 2012 Feb 07. 2223102
    View PubMed
  44. Jeong ID, Camilleri M, Shin A, Iturrino J, Boldingh A, Busciglio I, Burton D, Ryks M, Rhoten D, Zinsmeister AR. A randomised, placebo-controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Aliment Pharmacol Ther. 2012 Feb 21. [Epub ahead of print] 2226765
    View PubMed
  45. Smushkin G, Sathananthan A, Man CD, Zinsmeister AR, Camilleri M, Cobelli C, Rizza RA, Vella A. Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. J Clin Endocrinol Metab. 2012 Feb; 97(2):589-98. Epub 2011 Nov 16. 2222926
    View PubMed
  46. Sathananthan A, Dalla Man C, Zinsmeister AR, Camilleri M, Rodeheffer RJ, Toffolo G, Cobelli C, Rizza RA, Vella A. A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. Clin Endocrinol (Oxf). 2012 Feb; 76(2):212-9. 2226591
    View PubMed
  47. Camilleri M. Pharmacology of the new treatments for lower gastrointestinal motility disorders and irritable bowel syndrome. Clin Pharmacol Ther. 2012 Jan; 91(1):44-59. Epub 2011 Nov 09. 2204944
    View PubMed
  48. Camilleri M, Nullens S, Nelsen T. Enteroendocrine and neuronal mechanisms in pathophysiology of acute infectious diarrhea. Dig Dis Sci. 2012 Jan; 57(1):19-27. Epub 2011 Oct 15. 2199637
    View PubMed
  49. Vazquez-Roque M, Camilleri M. Clarifications about linaclotide. Expert Rev Gastroenterol Hepatol. 2012 Jan; 6(1):15. 2210949
    View PubMed
  50. Camilleri M. Guanylate cyclase C signaling: an intestinal secretory pathway where bugs, genes and new drugs intersect. Genome Med. 2012; 4(6):50. Epub 2012 Jun 26. 2253890
    View PubMed
  51. Wong BS, Camilleri M, McKinzie S, Burton D, Graffner H, Zinsmeister AR. Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation. Am J Gastroenterol. 2011 Dec; 106(12):2154-64. Epub 2011 Aug 30. 2187702
    View PubMed
  52. Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, Torkvist L, Schmidt PT, Karling P, Ohlsson B, Duerr RH, Simren M, Lindberg G, Agreus L, Carlson P, Zinsmeister AR, D'Amato M. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011 Dec; 60(12):1671-7. Epub 2011 Jun 02. 2208998
    View PubMed
  53. Camilleri M. Response to sandner-kiesling. Am J Gastroenterol. 2011 Dec; 106(12):2200-1. 2209900
    View PubMed
  54. Camilleri M, Vazquez-Roque MI, Carlson P, Burton D, Wong BS, Zinsmeister AR. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders. Neurogastroenterol Motil. 2011 Nov; 23(11):995-9, e458. Epub 2011 Aug 24. 2187868
    View PubMed
  55. Wong BS, Camilleri M, Busciglio I, Carlson P, Szarka LA, Burton D, Zinsmeister AR. Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology. 2011 Nov; 141(5):1638-47.e1-7. Epub 2011 Jul 29. 2187874
    View PubMed
  56. Rao AS, Camilleri M, Eckert DJ, Busciglio I, Burton DD, Ryks M, Wong BS, Lamsam J, Singh R, Zinsmeister AR. Urine sugars for in vivo gut permeability: validation and comparisons in irritable bowel syndrome-diarrhea and controls. Am J Physiol Gastrointest Liver Physiol. 2011 Nov; 301(5):G919-28. Epub 2011 Aug 11. 2203597
    View PubMed
  57. Chey WD, Camilleri M, Chang L, Rikner L, Graffner H. A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol. 2011 Oct; 106(10):1803-12. Epub 2011 May 24. 2203841
    View PubMed
  58. Camilleri M, Carlson P, McKinzie S, Zucchelli M, D'Amato M, Busciglio I, Burton D, Zinsmeister AR. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil. 2011 Oct; 23(10):935-e398. Epub 2011 Jul 14. 2176139
    View PubMed
  59. Camilleri M. New treatment options for chronic constipation: mechanisms, efficacy and safety. Can J Gastroenterol. 2011 Oct; 25 Suppl B:29B-35B. 2236754
    View PubMed
  60. Iturrino J, Camilleri M, Busciglio I, Burton D, Zinsmeister AR. Effect of the alpha2delta ligand, pregabalin, on colonic sensory and motor functions in healthy adults. Am J Physiol Gastrointest Liver Physiol. 2011 Aug; 301(2):G377-84. Epub 2011 May 19. 2179451
    View PubMed
  61. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity. Neurogastroenterol Motil. 2011 Jul; 23(7):637-e257. Epub 2011 Apr 07. 2157422
    View PubMed
  62. Iturrino J, Camilleri M, Orrock JM. Mega-intestine after subtotal colectomy for constipation. Clin Gastroenterol Hepatol. 2011 Jul; 9(7):A38. Epub 2011 Mar 04. 2151616
    View PubMed
  63. Vazquez-Roque MI, Camilleri M, Carlson P, McKinzie S, Murray JA, Brantner TL, Burton DD, Zinsmeister AR. HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2011 Jun; 23(6):481-7. 2160218
    View PubMed
  64. Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ. A Klothobeta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology. 2011 Jun; 140(7):1934-42. Epub 2011 Mar 09. 2152029
    View PubMed
  65. Camilleri M, Breen M, Ryks M, Burton D. Proximal and overall gastric emptying of solids in patients with reduced gastric volume accommodation compared to matched controls. Dig Dis Sci. 2011 Jun; 56(6):1729-34. Epub 2011 Feb 17. 2147396
    View PubMed
  66. Vazquez-Roque M, Camilleri M. VELUSETRAG 5-HT(4) receptor agonist treatment of chronic constipation. Drugs Future. 2011 Jun; 36(6):447-54. 2190894
  67. Vazquez-Roque MI, Camilleri M, Vella A, Carlson P, Laugen J, Zinsmeister AR. Association of TCF7L2 allelic variations with gastric function, satiation, and GLP-1 levels. Clin Transl Sci. 2011 Jun; 4(3):183-7. 2173479
    View PubMed
  68. Vazquez Roque M, Camilleri M. Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation. Expert Rev Gastroenterol Hepatol. 2011 Jun; 5(3):301-10. 2290403
    View PubMed
  69. Camilleri M. Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation. Therap Adv Gastroenterol. 2011 May; 4(3):159-63. 2172251
    View PubMed
  70. Camilleri M. Opioid-induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol. 2011 May; 106(5):835-42; quiz 843. Epub 2011 Feb 22. 2151553
    View PubMed
  71. Breen M, Camilleri M, Burton D, Zinsmeister AR. Performance characteristics of the measurement of gastric volume using single photon emission computed tomography. Neurogastroenterol Motil. 2011 Apr; 23(4):308-15. Epub 2011 Jan 06. 2141666
    View PubMed
  72. Wong BS, Camilleri M. Lubiprostone for the treatment of opioid-induced bowel dysfunction. Expert Opin Pharmacother. 2011 Apr; 12(6):983-90. Epub 2011 Mar 09. 2151709
    View PubMed
  73. Camilleri M. Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease. Gut. 2011 Apr; 60(4):425-8. Epub 2011 Feb 02. 2147452
    View PubMed
  74. Camilleri M, Rothman M, Ho KF, Etropolski M. Validation of a bowel function diary for assessing opioid-induced constipation. Am J Gastroenterol. 2011 Mar; 106(3):497-506. Epub 2010 Nov 09. 2124114
    View PubMed
  75. Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil. 2011 Mar; 23(3):193-200. Epub 2010 Dec 15. 2136187
    View PubMed
  76. Rao SS, Camilleri M, Hasler WL, Maurer AH, Parkman HP, Saad R, Scott MS, Simren M, Soffer E, Szarka L. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil. 2011 Jan; 23(1):8-23. 2129757
    View PubMed
  77. Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol. 2011 Jan; 9(1):5-12; quiz e7. Epub 2010 Oct 15. 2121306
    View PubMed
  78. Wong BS, Camilleri M, Carlson PJ, Guicciardi ME, Burton D, McKinzie S, Rao AS, Zinsmeister AR, Gores GJ. A klotho beta variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology. 2011; 140(7):1934-42. 2173668
  79. Lacy BE, Talley NJ, Camilleri M. Functional dyspepsia: time to change clinical trial design? Am J Gastroenterol. 2010 Dec; 105(12):2525-9. 2136392
    View PubMed
  80. Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome. IDrugs. 2010 Dec; 13(12):921-8. 2136063
    View PubMed
  81. Rao AS, Wong BS, Camilleri M, Odunsi-Shiyanbade ST, McKinzie S, Ryks M, Burton D, Carlson P, Lamsam J, Singh R, Zinsmeister AR. Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis. Gastroenterology. 2010 Nov; 139(5):1549-58, 1558.e1. Epub 2010 Aug 04. 2110380
    View PubMed
  82. Camilleri M, Van Outryve MJ, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies. Aliment Pharmacol Ther. 2010 Nov; 32(9):1113-23. Epub 2010 Sep 16. 2124051
    View PubMed
  83. Camilleri M, T Odunsi-Shiyanbade S, I Vazquez-Roque M. Response to "Odunsi et al. Results for CM3 Cannot Be Extrapolated to Alginates in General". Obesity (Silver Spring) 2010 Nov; 18(11):2070. 2121137
    View PubMed
  84. Manabe N, Rao AS, Wong BS, Camilleri M. Emerging pharmacologic therapies for irritable bowel syndrome. Curr Gastroenterol Rep. 2010 Oct; 12(5):408-16. 2110370
    View PubMed
  85. Wong BS, Rao AS, Camilleri M, Manabe N, McKinzie S, Busciglio I, Burton DD, Ryks M, Zinsmeister AR. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health. Aliment Pharmacol Ther. 2010 Oct; 32(7):884-93. 2114817
    View PubMed
  86. Camilleri M, Bharucha AE. Behavioural and new pharmacological treatments for constipation: getting the balance right. Gut. 2010 Sep; 59(9):1288-96. 2112309
    View PubMed
  87. Sathananthan A, Man CD, Micheletto F, Zinsmeister AR, Camilleri M, Giesler PD, Laugen JM, Toffolo G, Rizza RA, Cobelli C, Vella A. Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study. Diabetes Care. 2010 Sep; 33(9):2074-6. 2114934
    View PubMed
  88. Camilleri M, Tack JF. Current medical treatments of dyspepsia and irritable bowel syndrome. Gastroenterol Clin North Am. 2010 Sep; 39(3):481-93. 2121149
    View PubMed
  89. Odunsi ST, Vazquez-Roque MI, Camilleri M, Papathanasopoulos A, Clark MM, Wodrich L, Lempke M, McKinzie S, Ryks M, Burton D, Zinsmeister AR. Effect of alginate on satiation, appetite, gastric function, and selected gut satiety hormones in overweight and obesity. Obesity (Silver Spring). 2010 Aug; 18(8):1579-84. Epub 2009 Dec 03. 1975536
    View PubMed
  90. Spiegel BM, Roberts L, Mody R, Harding G, Kothari-Talwar S, Kahrilas PJ, Camilleri ML, Dabbous O, Revicki DA. The development and validation of a Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire for adults. Aliment Pharmacol Ther. 2010 Aug; 32(4):591-602. Epub 2010 Jun 02. 2109555
    View PubMed
  91. Camilleri M, Thorne NK, Ringel Y, Hasler WL, Kuo B, Esfandyari T, Gupta A, Scott SM, McCallum RW, Parkman HP, Soffer E, Wilding GE, Semler JR, Rao SS. Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil. 2010 Aug; 22(8):874-82, e233. Epub 2010 May 11. 1999692
    View PubMed
  92. Papathanasopoulos A, Camilleri M, Carlson PJ, Vella A, Nord SJ, Burton DD, Odunsi ST, Zinsmeister AR. A preliminary candidate genotype-intermediate phenotype study of satiation and gastric motor function in obesity. Obesity (Silver Spring). 2010 Jun; 18(6):1201-11. Epub 2009 Oct 29. 1970504
    View PubMed
  93. Rashtak S, Marietta E, Cheng S, Camilleri M, Pittelkow M, David C, Grande J, Murray J. Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. Lupus. 2010 Jun; 19(7):815-29. Epub 2010 Feb 08. 1985052
    View PubMed
  94. Camilleri M. Scintigraphic biomarkers for colonic dysmotility. Clin Pharmacol Ther. 2010 Jun; 87(6):748-53. Epub 2010 Apr 21. 1997822
    View PubMed
  95. Manabe N, Wong BS, Camilleri M. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders. Expert Opin Investig Drugs. 2010 Jun; 19(6):765-75. 1997827
    View PubMed
  96. Manabe N, Camilleri M, Rao A, Wong BS, Burton D, Busciglio I, Zinsmeister AR, Haruma K. Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol. 2010 Jun; 298(6):G970-5. Epub 2010 Apr 08. 2002175
    View PubMed
  97. Deiteren A, Camilleri M, Bharucha AE, Burton D, McKinzie S, Rao AS, Zinsmeister AR. Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions. Neurogastroenterol Motil. 2010 Apr; 22(4):415-23, e95. Epub 2009 Dec 18. 1978294
    View PubMed
  98. Manabe N, Wong BS, Camilleri M, Burton D, McKinzie S, Zinsmeister AR. Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort. Neurogastroenterol Motil. 2010 Mar; 22(3):293-e82. Epub 2009 Dec 21. 1978293
    View PubMed
  99. Odunsi ST, Camilleri M, Bharucha AE, Papathanasopoulos A, Busciglio I, Burton D, Zinsmeister AR. Reproducibility and performance characteristics of colonic compliance, tone, and sensory tests in healthy humans. Dig Dis Sci. 2010 Mar; 55(3):709-15. Epub 2009 Mar 17. 1931906
    View PubMed
  100. Spiller R, Camilleri M, Longstreth GF. Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? Clin Gastroenterol Hepatol. 2010 Feb; 8(2):125-9; discussion 129-36. 2102180
    View PubMed
  101. Odunsi-Shiyanbade ST, Camilleri M, McKinzie S, Burton D, Carlson P, Busciglio IA, Lamsam J, Singh R, Zinsmeister AR. Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):159-65. Epub 2009 Oct 30. 1970489
    View PubMed
  102. Deiteren A, Camilleri M, Burton D, McKinzie S, Rao A, Zinsmeister AR. Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome. Dig Dis Sci. 2010 Feb; 55(2):384-91. 1974041
    View PubMed
  103. Bharucha AE, Kulkarni A, Choi KM, Camilleri M, Lempke M, Brunn GJ, Gibbons SJ, Zinsmeister AR, Farrugia G. First-in-human study demonstrating pharmacological activation of heme oxygenase-1 in humans. Clin Pharmacol Ther. 2010 Feb; 87(2):187-90. Epub 2009 Dec 02. 1975556
    View PubMed
  104. Camilleri M, Deiteren A. Prucalopride for constipation. Expert Opin Pharmacother. 2010 Feb; 11(3):451-61. 1983180
    View PubMed
  105. Parkman HP, Camilleri M, Farrugia G, McCallum RW, Bharucha AE, Mayer EA, Tack JF, Spiller R, Horowitz M, Vinik AI, Galligan JJ, Pasricha PJ, Kuo B, Szarka LA, Marciani L, Jones K, Parrish CR, Sandroni P, Abell T, Ordog T, Hasler W, Koch KL, Sanders K, Gastroparesis and functional dyspepsia: excerpts from the AGA/ANMS meeting. Neurogastroenterol Motil. 2010 Feb; 22(2):113-33. Epub 2009 Dec 09. 1983244
    View PubMed
  106. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. "Associations among binge eating behavior patterns and gastrointestinal symptoms: A population-based study": Corrigendum. Int J Obes. 2010 Jan; 34(1):214. 2164071
  107. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2010 Jan; 31(1):11-9. 1971374
    View PubMed
  108. Papathanasopoulos A, Camilleri M. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology. 2010 Jan; 138(1):65-72.e1-2. Epub 2009 Nov 18. 1974116
    View PubMed
  109. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2010 Jan; 31(1):35-46. 1965338
    View PubMed
  110. Szarka LA, Camilleri M. Stomach dysfunction in diabetes mellitus: emerging technology and pharmacology. J Diabetes Sci Technol. 2010 Jan; 4(1):180-9. Epub 2010 Jan 01. 1987797
    View PubMed
  111. Camilleri M, Nadeau A, Lamsam J, Nord SL, Ryks M, Burton D, Sweetser S, Zinsmeister AR, Singh R. Understanding measurements of intestinal permeability in healthy humans with urine lactulose and mannitol excretion. Neurogastroenterol Motil. 2010 Jan; 22(1):e15-26. Epub 2009 Jul 13. 1980560
    View PubMed
  112. Camilleri M, Parke DW 2nd. Perspective: Conflict of interest and professional organizations: considerations and recommendations. Acad Med. 2010 Jan; 85(1):85-91. 1978227
    View PubMed
  113. Manini ML, Camilleri M, Goldberg M, Sweetser S, McKinzie S, Burton D, Wong S, Kitt MM, Li YP, Zinsmeister AR. Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation. Neurogastroenterol Motil. 2010 Jan; 22(1):42-9, e7-8. Epub 2009 Aug 18. 1959310
    View PubMed
  114. Ravi K, Bharucha AE, Camilleri M, Rhoten D, Bakken T, Zinsmeister AR. Phenotypic variation of colonic motor functions in chronic constipation. Gastroenterology. 2010 Jan; 138(1):89-97. Epub 2009 Aug 04. 1959356
    View PubMed
  115. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zucchelli M, D'Amato M. Neuropeptide S receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology. 2010 Jan; 138(1):98-107.e4. Epub 2009 Sep 02. 1960636
    View PubMed
  116. Wong BS, Manabe N, Camilleri M. Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation. Clin Exp Gastroenterol. 2010; 3:49-56. Epub 2010 May 24. 2173561
    View PubMed
  117. Camilleri M, Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis. 2009 Dec; 41(12):854-62. Epub 2009 Aug 08. 1957543
    View PubMed
  118. Camilleri M, Beyens G, Kerstens R, Robinson P, Vandeplassche L. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study. Neurogastroenterol Motil. 2009 Dec; 21(12):1256-e117. Epub 2009 Sep 09. 1962138
    View PubMed
  119. Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE. Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report. Gastroenterology. 2009 Dec; 137(6):1944-53.e1-3. Epub 2009 Aug 23. 1978932
    View PubMed
  120. Manabe N, Cremonini F, Camilleri M, Sandborn WJ, Burton DD. Effects of bisacodyl on ascending colon emptying and overall colonic transit in healthy volunteers. Aliment Pharmacol Ther. 2009 Nov 1; 30(9):930-6. Epub 2009 Aug 12. 1959350
    View PubMed
  121. Camilleri M. Genetics and irritable bowel syndrome: from genomics to intermediate phenotype and pharmacogenetics. Dig Dis Sci. 2009 Nov; 54(11):2318-24. Epub 2009 Aug 05. 1956947
    View PubMed
  122. Camilleri M. Do the Symptom-Based, Rome Criteria of Irritable Bowel Syndrome Lead to Better Diagnosis and Treatment Outcomes? The Con Argument. Clin Gastroenterol Hepatol. 2009 Oct 20; 8(2):129. [Epub ahead of print] 1987723
    View PubMed
  123. Keller J, Andresen V, Wolter J, Layer P, Camilleri M. Influence of clinical parameters on the results of 13C-octanoic acid breath tests: examination of different mathematical models in a large patient cohort. Neurogastroenterol Motil. 2009 Oct; 21(10):1039-e83. Epub 2009 Jun 22. 1968150
    View PubMed
  124. Revicki DA, Camilleri M, Kuo B, Norton NJ, Murray L, Palsgrove A, Parkman HP. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther. 2009 Sep 15; 30(6):670-80. Epub 2009 Jun 25. 1968234
    View PubMed
  125. Gathaiya N, Locke GR 3rd, Camilleri M, Schleck CD, Zinsmeister AR, Talley NJ. Novel associations with dyspepsia: a community-based study of familial aggregation, sleep dysfunction and somatization. Neurogastroenterol Motil. 2009 Sep; 21(9):922-e69. Epub 2009 Jun 02. 1978319
    View PubMed
  126. Camilleri M. Peripheral mechanisms in the control of appetite and related experimental therapies in obesity. Regul Pept. 2009 Aug 7; 156(1-3):24-7. Epub 2009 May 03. 1940746
    View PubMed
  127. Szarka LA, Camilleri M. Gastric emptying. Clin Gastroenterol Hepatol. 2009 Aug; 7(8):823-7. Epub 2009 Apr 24. 1951259
    View PubMed
  128. Izzo AA, Camilleri M. Cannabinoids in intestinal inflammation and cancer. Pharmacol Res. 2009 Aug; 60(2):117-25. Epub 2009 Mar 18. 1965724
    View PubMed
  129. Camilleri M, Nadeau A, Tremaine WJ, Lamsam J, Burton D, Odunsi S, Sweetser S, Singh R. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009 Jul; 21(7):734-e43. Epub 2009 Mar 13. 1937437
    View PubMed
  130. Odunsi ST, Camilleri M, Szarka LA, Zinsmeister AR. Optimizing analysis of stable isotope breath tests to estimate gastric emptying of solids. Neurogastroenterol Motil. 2009 Jul; 21(7):706-e38. Epub 2009 Feb 27. 1933690
    View PubMed
  131. Bernard CE, Gibbons SJ, Gomez-Pinilla PJ, Lurken MS, Schmalz PF, Roeder JL, Linden D, Cima RR, Dozois EJ, Larson DW, Camilleri M, Zinsmeister AR, Pozo MJ, Hicks GA, Farrugia G. Effect of age on the enteric nervous system of the human colon. Neurogastroenterol Motil. 2009 Jul; 21(7):746-e46. Epub 2009 Feb 08. 1925082
    View PubMed
  132. Sweetser S, Camilleri M, Linker Nord SJ, Burton DD, Castenada L, Croop R, Tong G, Dockens R, Zinsmeister AR. Do corticotropin releasing factor-1 receptors influence colonic transit and bowel function in women with irritable bowel syndrome? Am J Physiol Gastrointest Liver Physiol. 2009 Jun; 296(6):G1299-306. Epub 2009 Apr 02. 1935395
    View PubMed
  133. Camilleri M, Papathanasopoulos A, Odunsi ST. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2009 Jun; 6(6):343-52. 1942136
    View PubMed
  134. Odunsi ST, Camilleri M. Selected interventions in nuclear medicine: gastrointestinal motor functions. Semin Nucl Med. 2009 May; 39(3):186-94. 1935400
    View PubMed
  135. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Pharmacogenetics of low dose clonidine in irritable bowel syndrome. Neurogastroenterol Motil. 2009 Apr; 21(4):399-410. 1933691
    View PubMed
  136. Camilleri M. Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut? J Pediatr Gastroenterol Nutr. 2009 Apr; 48 Suppl 2:S46-8. 1933665
    View PubMed
  137. Camilleri M. The stomach in diabetes: from villain to ally. Clin Gastroenterol Hepatol. 2009 Mar; 7(3):285-7. Epub 2008 Nov 06. 1915212
    View PubMed
  138. Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009 Mar; 33(3):342-53. Epub 2009 Jan 13. 1914901
    View PubMed
  139. Camilleri M, Toouli J, Herrera MF, Kow L, Pantoja JP, Billington CJ, Tweden KS, Wilson RR, Moody FG. Selection of electrical algorithms to treat obesity with intermittent vagal block using an implantable medical device. Surg Obes Relat Dis. 2009 Mar-Apr; 5(2):224-9; discussion 229-30. Epub 2008 Sep 12. 1915406
    View PubMed
  140. Floyd BN, Camilleri M, Busciglio I, Sweetser S, Burton D, Wong GY, Kell S, Khanna S, Hwang S, Zinsmeister AR. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers. Neurogastroenterol Motil. 2009 Mar; 21(3):281-90. Epub 2008 Sep 23. 1915600
    View PubMed
  141. Szarka LA, Camilleri M. Methods for measurement of gastric motility. Am J Physiol Gastrointest Liver Physiol. 2009 Mar; 296(3):G461-75. Epub 2009 Jan 15. 1920628
    View PubMed
  142. Camilleri M, Carlson P, Zinsmeister AR, McKinzie S, Busciglio I, Burton D, Zaki EA, Boles RG. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders. Am J Physiol Gastrointest Liver Physiol. 2009 Mar; 296(3):G510-6. Epub 2009 Jan 15. 1920629
    View PubMed
  143. Bharucha AE, Camilleri M, Forstrom LA, Zinsmeister AR. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol (Oxf) 2009 Mar; 70(3):415-20. Epub 2008 Aug 22. 1915716
    View PubMed
  144. Manini ML, Burton DD, Meixner DD, Eckert DJ, Callstrom M, Schmit G, El-Youssef M, Camilleri M. Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents. J Pediatr Gastroenterol Nutr. 2009 Mar; 48(3):287-93. 1931951
    View PubMed
  145. Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2009 Feb; 16(1):53-9. 1921580
    View PubMed
  146. Cremonini F, Camilleri M, Zinsmeister AR, Herrick LM, Beebe T, Talley NJ. Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population. Neurogastroenterol Motil. 2009 Feb; 21(2):128-35. Epub 2008 Sep 18. 1914574
    View PubMed
  147. Sweetser S, Busciglio IA, Camilleri M, Bharucha AE, Szarka LA, Papathanasopoulos A, Burton DD, Eckert DJ, Zinsmeister AR. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Am J Physiol Gastrointest Liver Physiol. 2009 Feb; 296(2):G295-301. Epub 2008 Nov 25. 1915307
    View PubMed
  148. Rao AS, Camilleri M. Review article: metoclopramide and tardive dyskinesia. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):11-9. 1978946
    View PubMed
  149. Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2009 Jan 1; 31(1):35-46. 1978947
    View PubMed
  150. Gibbons SJ, De Giorgio R, Faussone Pellegrini MS, Garrity-Park MM, Miller SM, Schmalz PF, Young-Fadok TM, Larson DW, Dozois EJ, Camilleri M, Stanghellini V, Szurszewski JH, Farrugia G. Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil. 2009 Jan; 21(1):85-93. Epub 2008 Sep 16. 2235473
    View PubMed
  151. Fidler J, Bharucha AE, Camilleri M, Camp J, Burton D, Grimm R, Riederer SJ, Robb RA, Zinsmeister AR. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil. 2009 Jan; 21(1):42-51. Epub 2008 Oct 06. 1915348
    View PubMed
  152. Dalla Man C, Bock G, Giesler PD, Serra DB, Ligueros Saylan M, Foley JE, Camilleri M, Toffolo G, Cobelli C, Rizza RA, Vella A. Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes. Diabetes Care. 2009 Jan; 32(1):14-8. Epub 2008 Oct 17. 1933366
    View PubMed
  153. Camilleri M. Drug development and IBS drugs: experience from the past, current challenges, and proposal for the future. Curr Opin Pharmacol. 2008 Dec; 8(6):671-6. Epub 2008 Jul 09. 1915829
    View PubMed
  154. Camilleri M, Bharucha AE, di Lorenzo C, Hasler WL, Prather CM, Rao SS, Wald A. American Neurogastroenterology and Motility Society consensus statement on intraluminal measurement of gastrointestinal and colonic motility in clinical practice. Neurogastroenterol Motil. 2008 Dec; 20(12):1269-82. 1915347
    View PubMed
  155. Camilleri M, Chang L. Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles. Gastroenterology. 2008 Dec; 135(6):1877-91. Epub 2008 Oct 09. 1915548
    View PubMed
  156. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Deacon CF, Foley JE, Rizza RA, Camilleri M. The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study. Clin Endocrinol (Oxf). 2008 Nov; 69(5):737-44. Epub 2008 Mar 10. 1915926
    View PubMed
  157. Grudell AB, Sweetser S, Camilleri M, Eckert DJ, Vazquez-Roque MI, Carlson PJ, Burton DD, Braddock AE, Clark MM, Graszer KM, Kalsy SA, Zinsmeister AR. A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults. Gastroenterology. 2008 Oct; 135(4):1142-54. Epub 2008 Jul 16. 1909255
    View PubMed
  158. Camilleri M. Probiotics and irritable bowel syndrome: rationale, mechanisms, and efficacy. J Clin Gastroenterol. 2008 Sep; 42 Suppl 3 Pt 1:S123-5. 1915601
    View PubMed
  159. Bharucha AE, Charkoudian N, Andrews CN, Camilleri M, Sletten D, Zinsmeister AR, Low PA. Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans. Am J Physiol Regul Integr Comp Physiol. 2008 Sep; 295(3):R874-80. Epub 2008 Jul 02. 1904643
    View PubMed
  160. Camilleri M. Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. Neurogastroenterol Motil. 2008 Sep; 20(9):971-9. 1904892
    View PubMed
  161. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut. 2008 Aug; 57(8):1140-55. Epub 2008 Apr 08. 1909510
    View PubMed
  162. Camilleri M. New therapeutic approaches in irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2008 Aug; 12 Suppl 1:139-40. 1909259
    View PubMed
  163. Bharucha AE, Skaar T, Andrews CN, Camilleri M, Philips S, Seide B, Burton D, Baxter K, Zinsmeister AR. Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. 2008 Aug; 20(8):891-9. Epub 2008 Apr 16. 1904706
    View PubMed
  164. Bouras EP, Talley NJ, Camilleri M, Burton DD, Heckman MG, Crook JE, Richelson E. Effects of amitriptyline on gastric sensorimotor function and postprandial symptoms in healthy individuals: a randomized, double-blind, placebo-controlled trial. Am J Gastroenterol. 2008 Aug; 103(8):2043-50. 1904610
    View PubMed
  165. Bharucha AE, Low PA, Camilleri M, Burton D, Gehrking TL, Zinsmeister AR. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res. 2008 Aug; 18(4):194-202. Epub 2008 Jul 11. 1902490
    View PubMed
  166. Camilleri M, Busciglio I, Carlson P, McKinzie S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2):G219-25. Epub 2008 May 29. 1898980
    View PubMed
  167. Delgado-Aros S, Camilleri M, Garcia MA, Burton D, Busciglio I. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol. 2008 Aug; 295(2):G382-8. Epub 2008 Jul 10. 1949967
    View PubMed
  168. Camilleri M, McKinzie S, Busciglio I, Low PA, Sweetser S, Burton D, Baxter K, Ryks M, Zinsmeister AR. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008 Jul; 6(7):772-81. Epub 2008 May 05. 1898773
    View PubMed
  169. Andresen V, Camilleri M. Linaclotide acetate guanylate cyclase C receptor agonist treatment of irritable bowel syndrome treatment of constipation. Drugs Future. 2008 Jul; 33(7):570-6. 1955086
    View PubMed
  170. Talley NJ, Choung RS, Camilleri M, Dierkhising RA, Zinsmeister AR. Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. Aliment Pharmacol Ther. 2008 Jun 1; 27(11):1122-31. Epub 2008 Mar 07. 1902517
    View PubMed
  171. Szarka LA, Camilleri M, Vella A, Burton D, Baxter K, Simonson J, Zinsmeister AR. A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research. Clin Gastroenterol Hepatol. 2008 Jun; 6(6):635-643.e1. Epub 2008 Apr 14. 1892687
    View PubMed
  172. Camilleri M, Toouli J, Herrera MF, Kulseng B, Kow L, Pantoja JP, Marvik R, Johnsen G, Billington CJ, Moody FG, Knudson MB, Tweden KS, Vollmer M, Wilson RR, Anvari M. Intra-abdominal vagal blocking (VBLOC therapy): clinical results with a new implantable medical device. Surgery. 2008 Jun; 143(6):723-31. Epub 2008 May 09. 1885111
    View PubMed
  173. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med. 2008 May 29; 358(22):2344-54. 1883037
    View PubMed
  174. Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M. Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2008 May; 6(5):545-55. Epub 2008 Jan 31. 1888411
    View PubMed
  175. Grudell AB, Camilleri M, Jensen KL, Foxx-Orenstein AE, Burton DD, Ryks MD, Baxter KL, Cox DS, Dukes GE, Kelleher DL, Zinsmeister AR. Dose-response effect of a beta3-adrenergic receptor agonist, solabegron, on gastrointestinal transit, bowel function, and somatostatin levels in health. Am J Physiol Gastrointest Liver Physiol. 2008 May; 294(5):G1114-9. Epub 2008 Mar 27. 1877456
    View PubMed
  176. Vella A, Camilleri M. Pharmacogenetics: potential role in the treatment of diabetes and obesity. Expert Opin Pharmacother. 2008 May; 9(7):1109-19. 1877177
    View PubMed
  177. Sweetser S, Camilleri M. Clinical challenges and images in GI. Hindgut dysgenesis with megacolon. Gastroenterology. 2008 May; 134(5):1293, 1635. 1883040
    View PubMed
  178. Topazian M, Camilleri M, De La Mora-Levy J, Enders FB, Foxx-Orenstein AE, Levy MJ, Nehra V, Talley NJ. Endoscopic ultrasound-guided gastric botulinum toxin injections in obese subjects: a pilot study. Obes Surg. 2008 Apr; 18(4):401-7. Epub 2008 Feb 20. 1899017
    View PubMed
  179. Floyd BN, Camilleri M, Andresen V, Esfandyari T, Busciglio I, Zinsmeister AR. Comparison of mathematical methods for calculating colonic compliance in humans: power exponential, computer-based and manual linear interpolation models. Neurogastroenterol Motil. 2008 Apr; 20(4):330-5. Epub 2007 Oct 25. 1888375
    View PubMed
  180. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil. 2008 Apr; 20(4):418-29. 1888376
    View PubMed
  181. Grudell AB, Camilleri M, Carlson P, Gorman H, Ryks M, Burton D, Baxter K, Zinsmeister AR. An exploratory study of the association of adrenergic and serotonergic genotype and gastrointestinal motor functions. Neurogastroenterol Motil. 2008 Mar; 20(3):213-9. Epub 2007 Oct 17. 1869929
    View PubMed
  182. Camilleri M, Cowen T, Koch TR. Enteric neurodegeneration in ageing. Neurogastroenterol Motil. 2008 Mar; 20(3):185-96. 1900892
    View PubMed
  183. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008 Mar; 103(3):753-63. Epub 2007 Nov 19. 1966420
    View PubMed
  184. Abell TL, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, McCallum RW, Nowak T, Nusynowitz ML, Parkman HP, Shreve P, Szarka LA, Snape WJ Jr, Ziessman HA, American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. J Nucl Med Technol. 2008 Mar; 36(1):44-54. Epub 2008 Feb 20. 1990413
    View PubMed
  185. Aerssens J, Camilleri M, Talloen W, Thielemans L, Gohlmann HW, Van Den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008 Feb; 6(2):194-205. 1899244
    View PubMed
  186. Camilleri M, Carlson P, McKinzie S, Grudell A, Busciglio I, Burton D, Baxter K, Ryks M, Zinsmeister AR. Genetic variation in endocannabinoid metabolism, gastrointestinal motility, and sensation. Am J Physiol Gastrointest Liver Physiol. 2008 Jan; 294(1):G13-9. Epub 2007 Oct 25. 1861340
    View PubMed
  187. Camilleri M, Saito YA. Pharmacogenomics in gastrointestinal disorders. Methods Mol Biol. 2008; 448:395-412. 1877144
    View PubMed
  188. Mariani A, Camilleri M, Petersen IA, Ward EM, Farrugia G, Kelly DG, Podratz KC. Audit of suspected chronic intestinal pseudo-obstruction in patients with gynecologic cancer. Eur J Gynaecol Oncol. 2008; 29(6):578-82. 1903978
    View PubMed
  189. Camilleri M, Andresen V, Keller J, Layer P, Montori V. Pharmacological and non-pharmacological interventions for symptomatic gastroparesis. Cochrane Database Syst Rev. 2008; (2):CD007116. 1978447
    View PubMed
  190. Choi KM, Zhu J, Stoltz GJ, Vernino S, Camilleri M, Szurszewski JH, Gibbons SJ, Farrugia G. Determination of gastric emptying in nonobese diabetic mice. Am J Physiol Gastrointest Liver Physiol. 2007 Nov; 293(5):G1039-45. Epub 2007 Sep 20. 1853432
    View PubMed
  191. Szarka LA, Camilleri M, Burton D, Fox JC, McKinzie S, Stanislav T, Simonson J, Sullivan N, Zinsmeister AR. Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007 Nov; 5(11):1268-75. Epub 2007 Sep 27. 1853515
    View PubMed
  192. Beebe TJ, Talley NJ, Camilleri M, Jenkins SM, Anderson KJ, Locke GR 3rd. The HIPAA authorization form and effects on survey response rates, nonresponse bias, and data quality: a randomized community study. Med Care. 2007 Oct; 45(10):959-65. 1846320
    View PubMed
  193. Camilleri M. alpha2delta ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome? Gut. 2007 Oct; 56(10):1337-8. 1844582
    View PubMed
  194. Foxx-Orenstein AE, Camilleri M, Szarka LA, McKinzie S, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial. Neurogastroenterol Motil. 2007 Oct; 19(10):821-30. Epub 2007 May 21. 1844496
    View PubMed
  195. Camilleri M. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am. 2007 Sep; 36(3):649-64, xi-x. 1858451
    View PubMed
  196. Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D, McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM, Currie MG, Zinsmeister AR. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology. 2007 Sep; 133(3):761-8. Epub 2007 Jul 03. 1841449
    View PubMed
  197. Tremaine WJ, Camilleri M. Ethical issues concerning therapeutic studies in inflammatory bowel disease. Inflamm Bowel Dis. 2007 Sep; 13(9):1141-5. 1841443
    View PubMed
  198. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide BM, Burton DD, Nickander KK, Baxter KL, Zinsmeister AR. Effects of glucagon-like peptide-1 and sympathetic stimulation on gastric accommodation in humans. Neurogastroenterol Motil. 2007 Sep; 19(9):716-23. 1841282
    View PubMed
  199. Houghton LA, Cremonini F, Camilleri M, Busciglio I, Fell C, Cox V, Alpers DH, Dewit OE, Dukes GE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol Motil. 2007 Sep; 19(9):732-43. 1841283
    View PubMed
  200. Camilleri M. Pharmacogenomics and serotonergic agents: research observations and potential clinical practice implications. Neurogastroenterol Motil. 2007 Aug; 19 Suppl 2:40-5. 1834788
    View PubMed
  201. Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007 Jul; 19(7):545-52. 1830760
    View PubMed
  202. Esfandyari T, Camilleri M, Busciglio I, Burton D, Baxter K, Zinsmeister AR. Effects of a cannabinoid receptor agonist on colonic motor and sensory functions in humans: a randomized, placebo-controlled study. Am J Physiol Gastrointest Liver Physiol. 2007 Jul; 293(1):G137-45. Epub 2007 Mar 29. 1834827
    View PubMed
  203. Vazquez Roque MI, Camilleri M, Clark MM, Tepoel DA, Jensen MD, Graszer KM, Kalsy SA, Burton DD, Baxter KL, Zinsmeister AR. Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine. Clin Gastroenterol Hepatol. 2007 Jul; 5(7):829-37. Epub 2007 Jun 04. 1833003
    View PubMed
  204. Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M. Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes. 2007 May; 56(5):1475-80. Epub 2007 Feb 15. 1824576
    View PubMed
  205. Camilleri M, Grudell AB. Appetite and obesity: a gastroenterologist's perspective. Neurogastroenterol Motil. 2007 May; 19(5):333-41. 1820514
    View PubMed
  206. Camilleri M, Mangel AW, Fehnel SE, Drossman DA, Mayer EA, Talley NJ. Primary endpoints for irritable bowel syndrome trials: a review of performance of endpoints. Clin Gastroenterol Hepatol. 2007 May; 5(5):534-40. Epub 2007 Apr 11. 1820544
    View PubMed
  207. Camilleri M, Cortese DA. Managing conflict of interest in clinical practice. Mayo Clin Proc. 2007 May; 82(5):607-14. 1824603
    View PubMed
  208. Andrews CN, Bharucha AE, Camilleri M, Low PA, Seide B, Burton D, Baxter K, Zinsmeister AR. Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults. Am J Physiol Gastrointest Liver Physiol. 2007 May; 292(5):G1359-65. Epub 2007 Feb 08. 1828060
    View PubMed
  209. Choung RS, Talley NJ, Peterson J, Camilleri M, Burton D, Harmsen WS, Zinsmeister AR. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenterol Motil. 2007 Mar; 19(3):180-7. 1807111
    View PubMed
  210. Camilleri M, Dubnansky EC, Rustgi AK. Conflicts of interest and disclosures in publications. Clin Gastroenterol Hepatol. 2007 Mar; 5(3):268-73. 1815173
    View PubMed
  211. Grudell AB, Camilleri M. The role of peptide YY in integrative gut physiology and potential role in obesity. Curr Opin Endocrinol Diabetes Obes. 2007 Feb; 14(1):52-7. 1859014
    View PubMed
  212. Camilleri M. Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment? Neurogastroenterol Motil. 2007 Feb; 19(2):77-84. 1802233
    View PubMed
  213. Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007 Jan; 19(Suppl 1):62-88. 1802235
    View PubMed
  214. Camilleri M, Andrews CN, Bharucha AE, Carlson PJ, Ferber I, Stephens D, Smyrk TC, Urrutia R, Aerssens J, Thielemans L, Gohlmann H, van den Wyngaert I, Coulie B. Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology. 2007 Jan; 132(1):17-25. Epub 2006 Nov 17. 1804976
    View PubMed
  215. Camilleri M, Vazquez-Roque MI, Burton D, Ford T, McKinzie S, Zinsmeister AR, Druzgala P. Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans. Neurogastroenterol Motil. 2007 Jan; 19(1):30-8. 1810643
    View PubMed
  216. Dalla Man C, Camilleri M, Cobelli C. A system model of oral glucose absorption: validation on gold standard data. IEEE Trans Biomed Eng. 2006 Dec; 53(12 Pt 1):2472-8. 1794498
    View PubMed
  217. Xue L, Camilleri M, Locke GR 3rd, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Serotonergic modulation of murine fundic tone. Am J Physiol Gastrointest Liver Physiol. 2006 Dec; 291(6):G1180-6. Epub 2006 Jul 27. 1791365
    View PubMed
  218. Camilleri M. Gastroenterology and hepatology clinical research update: 2005-2006. Clin Gastroenterol Hepatol. 2006 Dec; 4(12):1428-33. Epub 2006 Sep 01. 1799572
    View PubMed
  219. Vazquez Roque MI, Camilleri M, Stephens DA, Jensen MD, Burton DD, Baxter KL, Zinsmeister AR. Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people. Gastroenterology. 2006 Dec; 131(6):1717-24. Epub 2006 Oct 15. 1802103
    View PubMed
  220. Camilleri M. Is there a role for probiotics in irritable bowel syndrome? Dig Liver Dis. 2006 Dec; 38 Suppl 2:S266-9. 1892525
    View PubMed
  221. Chial HJ, Camilleri M. A twenty-one-year-old college student with postprandial regurgitation and weight loss. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1314-7. Epub 2006 Oct 23. 1792986
    View PubMed
  222. Cremonini F, Camilleri M, Vazquez Roque M, McKinzie S, Burton D, Baxter K, Zinsmeister AR. Obesity does not increase effects of synthetic ghrelin on human gastric motor functions. Gastroenterology. 2006 Nov; 131(5):1431-9. Epub 2006 Sep 20. 1968749
    View PubMed
  223. Grudell AB, Camilleri M, Burton DD, Stephens DA. Effect of a proton pump inhibitor on postprandial gastric volume, emptying and symptoms in healthy human subjects: a pilot study. Aliment Pharmacol Ther. 2006 Oct 1; 24(7):1037-43. 1782381
    View PubMed
  224. Saito YA, Camilleri M. Clinical application of pharmacogenetics in gastrointestinal diseases. Expert Opin Pharmacother. 2006 Oct; 7(14):1857-69. 1786719
    View PubMed
  225. Gonenne J, Esfandyari T, Camilleri M, Burton DD, Stephens DA, Baxter KL, Zinsmeister AR, Bharucha AE. Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. Neurogastroenterol Motil. 2006 Oct; 18(10):911-8. 1779638
    View PubMed
  226. Talley NJ, Camilleri M, Burton D, Thomforde G, Koch K, Rucker MJ, Peterson J, Zinsmeister AR, Earnest DL. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment Pharmacol Ther. 2006 Sep 1; 24(5):859-67. 1778043
    View PubMed
  227. Esfandyari T, Camilleri M, Ferber I, Burton D, Baxter K, Zinsmeister AR. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2006 Sep; 18(9):831-8. 1775754
    View PubMed
  228. Camilleri M. New imaging in neurogastroenterology: an overview. Neurogastroenterol Motil. 2006 Sep; 18(9):805-12. 1775755
    View PubMed
  229. Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006 Aug; 18(8):595-607. 1772782
    View PubMed
  230. Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology. 2006 Aug; 131(2):640-58. 1778017
    View PubMed
  231. Camilleri M. Management of patients with chronic abdominal pain in clinical practice. Neurogastroenterol Motil. 2006 Jul; 18(7):499-506. 1765283
    View PubMed
  232. Camilleri M. Does delayed gastric emptying really cause symptoms in functional dyspepsia? Gut. 2006 Jul; 55(7):909-10. 1765699
    View PubMed
  233. Andresen V, Camilleri M, Kim HJ, Stephens DA, Carlson PJ, Talley NJ, Saito YA, Urrutia R, Zinsmeister AR. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology. 2006 Jun; 130(7):1985-94. 1765702
    View PubMed
  234. Camilleri M, Bharucha AE, Ueno R, Burton D, Thomforde GM, Baxter K, McKinzie S, Zinsmeister AR. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006 May; 290(5):G942-7. 1757141
    View PubMed
  235. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part I: functional dyspepsia. Neurogastroenterol Motil. 2006 May; 18(5):346-53. 1758045
    View PubMed
  236. Andresen V, Camilleri M. Challenges in drug development for functional gastrointestinal disorders. Part II: visceral pain. Neurogastroenterol Motil. 2006 May; 18(5):354-60. 1758046
    View PubMed
  237. Park MI, Camilleri M. Gastroparesis: clinical update. Am J Gastroenterol. 2006 May; 101(5):1129-39. 1762852
    View PubMed
  238. Skoog SM, Bharucha AE, Camilleri M, Burton DD, Zinsmeister AR. Effects of an osmotically active agent on colonic transit. Neurogastroenterol Motil. 2006 Apr; 18(4):300-6. 1754250
    View PubMed
  239. Camilleri M, Bueno L, de Ponti F, Fioramonti J, Lydiard RB, Tack J. Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology. 2006 Apr; 130(5):1421-34. 1762801
    View PubMed
  240. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V. Functional gastroduodenal disorders. Gastroenterology. 2006 Apr; 130(5):1466-79. 1762803
    View PubMed
  241. Camilleri CE, Carlson PJ, Camilleri M, Castillo EJ, Locke GR 3rd, Geno DM, Stephens DA, Zinsmeister AR, Urrutia R. A study of candidate genotypes associated with dyspepsia in a U.S. community. Am J Gastroenterol. 2006 Mar; 101(3):581-92. Epub 2006 Feb 08. 1750573
    View PubMed
  242. Camilleri M. Probiotics and irritable bowel syndrome: rationale, putative mechanisms, and evidence of clinical efficacy. J Clin Gastroenterol. 2006 Mar; 40(3):264-9. 1758061
    View PubMed
  243. Floch MH, Madsen KK, Jenkins DJ, Guandalini S, Katz JA, Onderdonk A, Walker WA, Fedorak RN, Camilleri M. Recommendations for probiotic use. J Clin Gastroenterol. 2006 Mar; 40(3):275-8. 1758062
    View PubMed
  244. Xue L, Locke GR, Camilleri M, Schuurkes JA, Meulemans A, Coulie BJ, Szurszewski JH, Farrugia G. Effect of modulation of serotonergic, cholinergic, and nitrergic pathways on murine fundic size and compliance measured by ultrasonomicrometry. Am J Physiol Gastrointest Liver Physiol. 2006 Jan; 290(1):G74-82. Epub 2005 Sep 15. 1740292
    View PubMed
  245. Park MI, Ferber I, Camilleri M, Allenby K, Trillo R, Burton D, Zinsmeister AR. Effect of atilmotin on gastrointestinal transit in healthy subjects: a randomized, placebo-controlled study. Neurogastroenterol Motil. 2006 Jan; 18(1):28-36. 1750464
    View PubMed
  246. Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs. 2006; 66(8):1073-88. 1772820
    View PubMed
  247. Schiller LR, Camilleri M. Lubiprostone: profile report. Drugs and Therapy Perspectives. 2006; 22(9):5-6. 1971945
    View PubMed
  248. Camilleri M. GIH clinical research update: 2004-2005. Clin Gastroenterol Hepatol. 2005 Dec; 3(12):1161-6. 1743625
    View PubMed
  249. Cremonini F, Houghton LA, Camilleri M, Ferber I, Fell C, Cox V, Castillo EJ, Alpers DH, Dewit OE, Gray E, Lea R, Zinsmeister AR, Whorwell PJ. Barostat testing of rectal sensation and compliance in humans: comparison of results across two centres and overall reproducibility. Neurogastroenterology & Motility. 2005 Dec; 17(6):810-20. 1743692
    View PubMed
  250. Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating. Neurogastroenterol Motil. 2005 Oct; 17(5):687-96. 2240770
    View PubMed
  251. Delgado-Aros S, Camilleri M, Castillo EJ, Cremonini F, Stephens D, Ferber I, Baxter K, Burton D, Zinsmeister AR. Effect of gastric volume or emptying on meal-related symptoms after liquid nutrients in obesity: a pharmacologic study. Clin Gastroenterol Hepatol. 2005 Oct; 3(10):997-1006. 1739993
    View PubMed
  252. Camilleri M, Gamble GL, Kopecky SL, Wood MB, Hockema ML. Principles and process in the development of the Mayo Clinic's individual and institutional conflict of interest policy. Mayo Clin Proc. 2005 Oct; 80(10):1340-6. 1731989
    View PubMed
  253. Cremonini F, Camilleri M, Gonenne J, Stephens D, Oenning L, Baxter K, Foxx-Orenstein A, Burton D. Effect of somatostatin analog on postprandial satiation in obesity. Obes Res. 2005 Sep; 13(9):1572-9. 1732056
    View PubMed
  254. Gonenne J, Camilleri M, Ferber I, Burton D, Baxter K, Keyashian K, Foss J, Wallin B, Du W, Zinsmeister AR. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study. Clin Gastroenterol Hepatol. 2005 Aug; 3(8):784-91. 1740002
    View PubMed
  255. Burton DD, Kim HJ, Camilleri M, Stephens DA, Mullan BP, O'Connor MK, Talley NJ. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol Gastrointest Liver Physiol. 2005 Aug; 289(2):G261-6. 1721408
    View PubMed
  256. Camilleri M. Pharmacogenomics and functional gastrointestinal disorders. Pharmacogenomics. 2005 Jul; 6(5):491-501. 1729831
    View PubMed
  257. Nickander KK, Carlson PJ, Urrutia RA, Camilleri M, Low PA. A screen of candidate genes and influence of beta2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci. 2005 Jun 15; 120(1-2):97-103. 1721406
    View PubMed
  258. Park MI, Camilleri M. Genetics and genotypes in irritable bowel syndrome: implications for diagnosis and treatment. Gastroenterol Clin North Am. 2005 Jun; 34(2):305-17. 1718782
    View PubMed
  259. Camilleri M, Dubois D, Coulie B, Jones M, Kahrilas PJ, Rentz AM, Sonnenberg A, Stanghellini V, Stewart WF, Tack J, Talley NJ, Whitehead W, Revicki DA. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005 Jun; 3(6):543-52. 1729891
    View PubMed
  260. Delgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol. 2005 May-Jun; 39(5 Suppl 3):S194-203; discussion S210. 1708135
    View PubMed
  261. Chitkara DK, Camilleri M, Zinsmeister AR, Burton D, El-Youssef M, Freese D, Walker L, Stephens D. Gastric sensory and motor dysfunction in adolescents with functional dyspepsia. J Pediatr. 2005 Apr; 146(4):500-5. 1708081
    View PubMed
  262. Camilleri M. Alvimopan, a selective peripherally acting mu-opioid antagonist. Neurogastroenterol Motil. 2005 Apr; 17(2):157-65. 1705124
    View PubMed
  263. Cremonini F, Camilleri M, McKinzie S, Carlson P, Camilleri CE, Burton D, Thomforde G, Urrutia R, Zinsmeister AR. Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterol. 2005 Mar; 100(3):652-63. 1703820
    View PubMed
  264. Park MI, Camilleri M. Gastric motor and sensory functions in obesity. Obes Res. 2005 Mar; 13(3):491-500. 1708413
    View PubMed
  265. Gonenne J, Castillo EJ, Camilleri M, Burton D, Thomforde GM, Baxter KL, Zinsmeister AR. Does the nutrient drink test accurately predict postprandial gastric volume in health and community dyspepsia? Neurogastroenterol Motil. 2005 Feb; 17(1):44-50. 1694057
    View PubMed
  266. Talley NJ, Camilleri M, Chitkara DK, Bouras E, Locke GR, Burton D, Rucker MJ, Thapa P, Zinsmeister AR. Effects of desipramine and escitalopram on postprandial symptoms induced by the nutrient drink test in healthy volunteers: A randomized, double-blind, placebo-controlled study. Digestion. 2005; 72(2-3):97-103. 1732116
    View PubMed
  267. Camilleri M. Etiology and pathophysiology of irritable bowel syndrome and chronic constipation. Advanced Studies in Medicine. 2005; 5(10 B):S955-64. 1791169
    View PubMed
  268. Bouras EP, Burton DD, Camilleri M, Stephens DA, Thomforde GM. Effect of cyclooxygenase-2 inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil. 2004 Dec; 16(6):729-35. 1677684
    View PubMed
  269. Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology. 2004 Dec; 127(6):1685-94. 1677714
    View PubMed
  270. Castillo EJ, Camilleri M, Locke GR, Burton DD, Stephens DA, Geno DM, Zinsmeister AR. A community-based, controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol. 2004 Nov; 2(11):985-96. 1694025
    View PubMed
  271. Hicks GA, Dehaven-Hudkins DL, Camilleri M. Opiates in the control of gastrointestinal tract function: current knowledge and new avenues for research. Neurogastroenterol Motil. 2004 Oct; 16(Suppl 2):67-70. 1663702
    View PubMed
  272. De Giorgio R, Camilleri M. Human enteric neuropathies: morphology and molecular pathology. Neurogastroenterol Motil. 2004 Oct; 16(5):515-31. 1673893
    View PubMed
  273. De Schepper H, Camilleri M, Cremonini F, Foxx-Orenstein A, Burton D. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil. 2004 Oct; 16(5):567-73. 1673894
    View PubMed
  274. Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D, Thomforde G, Baxter K, Zinsmeister AR. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004 Oct; 2(10):895-904. 1680695
    View PubMed
  275. Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, Melton LJ. Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol. 2004 Sep; 99(9):1801-6. 1663591
    View PubMed
  276. Castillo EJ, Delgado-Aros S, Camilleri M, Burton D, Stephens D, O'Connor-Semmes R, Walker A, Shachoy-Clark A, Zinsmeister AR. Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2004 Aug; 287(2):G363-9. 1653816
    View PubMed
  277. De Schepper HU, Cremonini F, Park MI, Camilleri M. Opioids and the gut: pharmacology and current clinical experience. Neurogastroenterol Motil. 2004 Aug; 16(4):383-94. 1660707
    View PubMed
  278. Chitkara DK, Bredenoord AJ, Cremonini F, Delgado-Aros S, Smoot RL, El-Youssef M, Freese D, Camilleri M. The role of pelvic floor dysfunction and slow colonic transit in adolescents with refractory constipation. Am J Gastroenterol. 2004 Aug; 99(8):1579-84. 1662274
    View PubMed
  279. Vella A, Camilleri M, Rizza RA. The gastrointestinal tract and glucose tolerance. Curr Opin Clin Nutr Metab Care. 2004 Jul; 7(4):479-84. 1653752
    View PubMed
  280. Kim HJ, Camilleri M, Carlson PJ, Cremonini F, Ferber I, Stephens D, McKinzie S, Zinsmeister AR, Urrutia R. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut. 2004 Jun; 53(6):829-37. 1645499
    View PubMed
  281. Camilleri M. Advances in pharmacological treatments of IBS. J Pediatr Gastroenterol Nutr. 2004 Jun; 39 Suppl 3:S766-7. 1653729
    View PubMed
  282. De Schepper HU, Cremonini F, Chitkara D, Camilleri M. Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil. 2004 Jun; 16(3):275-85. 1652839
    View PubMed
  283. Camilleri M. Treating irritable bowel syndrome: overview, perspective and future therapies. Br J Pharmacol. 2004 Apr; 141(8):1237-48. Epub 2004 Mar 22. 1644343
    View PubMed
  284. Camilleri M, Talley NJ. Pathophysiology as a basis for understanding symptom complexes and therapeutic targets. Neurogastroenterol Motil. 2004 Apr; 16(2):135-42. 1643016
    View PubMed
  285. Camilleri M. Chronic diarrhea: a review on pathophysiology and management for the clinical gastroenterologist. Clinical Gastroenterology & Hepatology. 2004 Mar; 2(3):198-206. 1647218
    View PubMed
  286. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part II -- midgut and hindgut diseases. Clinical Geriatrics. 2004 Mar; 12(3):24, 25-7, 31-2. 1665852
    View PubMed
  287. Delgado-Aros S, Cremonini F, Castillo JE, Chial HJ, Burton DD, Ferber I, Camilleri M. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004 Feb; 126(2):432-40. 1520483
    View PubMed
  288. Camilleri M. Nonmalignant gastrointestinal syndromes in the elderly: part I -- alterations in physiology and foregut diseases. Clinical Geriatrics. 2004 Feb; 12(2):38-40, 41-3. 1665840
    View PubMed
  289. Delgado-Aros S, Camilleri M. [Clinical management of acute colonic pseudo-obstruction in patients: a systematic review of the literature]. [Review] [107 refs] [Spanish]. Gastroenterol Hepatol. 2003 Dec; 26(10):646-55. 1646961
    View PubMed
  290. Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut. 2003 Nov; 52(11):1555-61. 1422323
    View PubMed
  291. Chitkara DK, Delgado-Aros S, Bredenoord AJ, Cremonini F, El-Youssef M, Freese D, Camilleri M. Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr. 2003 Nov; 143(5):609-13. 1425118
    View PubMed
  292. Camilleri M. GI clinical research 2002-2003: the year in review. Clin Gastroenterol Hepatol. 2003 Nov; 1(6):415-20. 1646996
    View PubMed
  293. Lembo A, Camilleri M. Current concepts: Chronic constipation. N Engl J Med. 2003 Oct 2; 349(14):1360-8. 1415128
    View PubMed
  294. Delgado-Aros S, Chial HJ, Cremonini F, Ferber I, McKinzie S, Burton DD, Camilleri M. Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. Aliment Pharmacol Ther. 2003 Sep 1; 18(5):507-14. 1413669
    View PubMed
  295. Cremonini F, Di Caro S, Delgado-Aros S, Sepulveda A, Gasbarrini G, Gasbarrini A, Camilleri M. Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 2003 Aug 1; 18(3):279-89. 1405723
    View PubMed
  296. Delgado-Aros S, Vella A, Camilleri M, Low PA, Burton DD, Thomforde GM, Stephens D. Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction. Neurogastroenterol Motil. 2003 Aug; 15(4):435-43. 1404986
    View PubMed
  297. Zangeneh F, Basu R, Shah P, Arora P, Camilleri M, Rizza RA. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Am J Physiol Endocrinol Metab. 2003 Aug; 285(2):E280-6. 1405115
    View PubMed
  298. Delgado-Aros S, Cremonini F, Bredenoord AJ, Camilleri M. Systematic review and meta-analysis: does gall-bladder ejection fraction on cholecystokinin cholescintigraphy predict outcome after cholecystectomy in suspected functional biliary pain? Alimentary Pharmacology & Therapeutics. 2003 Jul 15; 18(2):167-74. 1405118
    View PubMed
  299. Bredenoord AJ, Chial HJ, Camilleri M, Mullan BP, Murray JA. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2003 Jul; 1(4):264-72. 1646994
    View PubMed
  300. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003 Jun; 98(6):1309-14. 1396887
    View PubMed
  301. Delgado-Aros S, Camilleri M. Pseudo-obstruction in the critically ill. Best Practice & Research in Clinical Gastroenterology. 2003 Jun; 17(3):427-44. 1396778
    View PubMed
  302. Chial HJ, Camilleri M, Ferber I, Delgado-Aros S, Burton D, McKinzie S, Zinsmeister AR. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Clin Gastroenterol Hepatol. 2003 May; 1(3):211-8. 1646989
    View PubMed
  303. Cremonini F, Camilleri M. Of actors, bolting horses, and drops in oceans! Gut. 2003 May; 52(5):619-21. 1340441
    View PubMed
  304. Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 2003 Apr 1; 17(7):895-904. 1328749
    View PubMed
  305. Delgado-Aros S, Chial HJ, Camilleri M, Szarka LA, Weber FT, Jacob J, Ferber I, McKinzie S, Burton DD, Zinsmeister AR. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol Gastrointest Liver Physiol. 2003 Apr; 284(4):G558-66. 1325120
    View PubMed
  306. Camilleri M, Kim DY, McKinzie S, Kim HJ, Thomforde GM, Burton DD, Low PA, Zinsmeister AR. A randomized, controlled exploratory study of clonidine in diarrhea-predominant irritable bowel syndrome. Clinical Gastroenterology & Hepatology. 2003 Mar; 1(2):111-21. 1646986
    View PubMed
  307. Camilleri M. Diagnosis and treatment of enteric neuromuscular diseases. Clin Auton Res. 2003 Feb; 13(1):10-5. 1340448
    View PubMed
  308. Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil. 2003 Feb; 15(1):79-86. 1318612
    View PubMed
  309. Chial HJ, Camilleri M, Williams DE, Litzinger K, Perrault J. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis. Pediatrics. 2003 Jan; 111(1):158-62. 1317928
    View PubMed
  310. Chial HJ, Camilleri M, Burton D, Thomforde G, Olden KW, Stephens D. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Am J Physiol Gastrointest Liver Physiol. 2003 Jan; 284(1):G130-7. 1317918
    View PubMed
  311. Camilleri M. Drugs targeting functional bowel disorders: lessons from drug trials. Current Opinion in Pharmacology. 2002 Dec; 2(6):684-90. 1416799
    View PubMed
  312. Bouras EP, Delgado-Aros S, Camilleri M, Castillo EJ, Burton DD, Thomforde GM, Chial HJ. SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut. 2002 Dec; 51(6):781-6. 1317080
    View PubMed
  313. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology. 2002 Dec; 123(6):2108-31. 1317366
    View PubMed
  314. Cremonini F, Mullan BP, Camilleri M, Burton DD, Rank MR. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Alimentary Pharmacology & Therapeutics. 2002 Oct; 16(10):1781-90. 1316259
    View PubMed
  315. Camilleri M, Atanasova E, Carlson PJ, Ahmad U, Kim HJ, Viramontes BE, McKinzie S, Urrutia R. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2002 Aug; 123(2):425-32. 1314959
    View PubMed
  316. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Effect of enteral vs. parenteral glucose delivery on initial splanchnic glucose uptake in nondiabetic humans. Am J Physiol Endocrinol Metab. 2002 Aug; 283(2):E259-66. 1314813
    View PubMed
  317. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 2002 Aug; 16(8):1407-30. 1315149
    View PubMed
  318. Camilleri M. Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls. Gut. 2002 Jul; 51 Suppl 1:i34-40. 1314871
    View PubMed
  319. Camilleri M. Serotonergic modulation of visceral sensation: lower gut. Gut. 2002 Jul; 51 Suppl 1:i81-6. 1314872
    View PubMed
  320. Chial HJ, Camilleri C, Delgado-Aros S, Burton D, Thomforde G, Ferber I, Camilleri M. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms: effects of gender, body mass index and age in health. Neurogastroenterol Motil. 2002 Jun; 14(3):249-53. 1315884
    View PubMed
  321. Chial HJ, Camilleri M. Gender differences in irritable bowel syndrome. J Gend Specif Med. 2002 May-Jun; 5(3):37-45. 1639555
    View PubMed
  322. Vella A, Lee JS, Camilleri M, Szarka LA, Burton DD, Zinsmeister AR, Rizza RA, Klein PD. Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus. Neurogastroenterol Motil. 2002 Apr; 14(2):123-31. 1315542
    View PubMed
  323. Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M. Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol. 2002 Mar; 282(3):G424-31. 1008422
    View PubMed
  324. Chial HJ, McAlpine DE, Camilleri M. Anorexia nervosa: Manifestations and management for the gastroenterologist. Am J Gastroenterol. 2002 Feb; 97(2):255-69. 1008283
    View PubMed
  325. Kuo B, Camilleri M, Burton D, Viramontes B, McKinzie S, Thomforde G, O'Connor MK, Brinkmann BH. Effects of 5-HT(3) antagonism on postprandial gastric volume and symptoms in humans. Aliment Pharmacol Ther. 2002 Feb; 16(2):225-33. 1008244
    View PubMed
  326. Camilleri M. Advances in diabetic gastroparesis. Reviews in Gastroenterological Disorders. 2002; 2(2):47-56. 1318477
    View PubMed
  327. Pardi DS, Loftus EV, Camilleri M. Treatment of inflammatory bowel disease in the elderly - An update. Drugs & Aging. 2002; 19(5):355-63. 1315008
    View PubMed
  328. Viramontes BE, Malcolm A, Camilleri M, Szarka LA, McKinzie S, Burton DD, Zinsmeister AR. Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol. 2001 Dec; 281(6):G1468-76. 1007041
    View PubMed
  329. Liau SS, Camilleri M, Kim DY, Stephens D, Burton DD, O'Connor MK. Pharmacological modulation of human gastric volumes demonstrated noninvasively using SPECT imaging. Neurogastroenterol Motil. 2001 Dec; 13(6):533-42. 1007338
    View PubMed
  330. Viramontes BE, Kim DY, Camilleri M, Lee JS, Stephens D, Burton DD, Thomforde GM, Klein PD, Zinsmeister AR. Validation of a stable isotope gastric emptying test for normal, accelerated or delayed gastric emptying. Neurogastroenterol Motil. 2001 Dec; 13(6):567-74. 1007340
    View PubMed
  331. Kim DY, Delgado-Aros S, Camilleri M, Samsom M, Murray JA, O'Connor MK, Brinkmann BH, Stephens DA, Lighvani SS, Burton DD. Noninvasive measurement of gastric accommodation in patients with idiopathic nonulcer dyspepsia. Am J Gastroenterol. 2001 Nov; 96(11):3099-105. 1007044
    View PubMed
  332. Kim DY, Camilleri M, Murray JA, Stephens DA, Levine JA, Burton DD. Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res. 2001 Nov; 9(11):655-61. 1006924
    View PubMed
  333. Viramontes BE, Camilleri M, McKinzie S, Pardi DS, Burton D, Thomforde GM. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001 Sep; 96(9):2671-6. 1004292
    View PubMed
  334. Camilleri M, Kim DY. What is the relevance of a systematic review of pharmacological management in irritable bowel syndrome to older people? Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. J Am Geriatr Soc. 2001 Sep; 49(9):1249-52. 1004288
    View PubMed
  335. Camilleri M. Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist. Neurogastroenterol Motil. 2001 Aug; 13(4):277-95. 1314675
    View PubMed
  336. Camilleri M, Chey WY, Mayer EA, Northcutt AR, Heath A, Dukes GE, McSorley D, Mangel AM. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome. Arch Intern Med. 2001 Jul 23; 161(14):1733-40. 1005624
    View PubMed
  337. Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barre syndrome. Muscle Nerve. 2001 Jul; 24(7):963-5. 1014837
    View PubMed
  338. Camilleri M. Pathophysiology in irritable bowel syndrome. Drug News Perspect. 2001 Jun; 14(5):268-78. 1006179
    View PubMed
  339. Bharucha AE, Camilleri M. Functional abdominal pain in the elderly. Gastroenterol Clin North Am. 2001 Jun; 30(2):517-29. 1005412
    View PubMed
  340. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk WF, Rizza RA. Type I diabetes mellitus does not alter initial splanchnic glucose extraction or hepatic UDP-glucose flux during enteral glucose administration. Diabetologia. 2001 Jun; 44(6):729-37. 1004513
    View PubMed
  341. Coulie B, Camilleri M, Bharucha AE, Sandborn WJ, Burton D. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine and colonic motility in patients and healthy subjects. Aliment Pharmacol Ther. 2001 May; 15(5):653-63. 1004892
    View PubMed
  342. Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol. 2001 May; 96(5):1494-8. 1004938
    View PubMed
  343. Camilleri M. Review article: tegaserod. Aliment Pharmacol Ther. 2001 Mar; 15(3):277-89. 1004736
    View PubMed
  344. Aros SD, Camilleri M. Small-bowel motility. Curr Opin Gastroenterol. 2001 Mar; 17(2):140-146. 1004742
    View PubMed
  345. Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001 Mar; 50(3):565-72. 1003674
    View PubMed
  346. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology. 2001 Feb; 120(3):652-68. 1004737
    View PubMed
  347. Lee HR, Lennon VA, Camilleri M, Prather CM. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001 Feb; 96(2):373-9. 1003608
    View PubMed
  348. Bouras EP, Camilleri M, Burton DD, Thomforde G, McKinzie S, Zinsmeister AR. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001 Feb; 120(2):354-60. 1003493
    View PubMed
  349. Camilleri M, Coulie B, Tack JF. Visceral hypersensitivity: facts, speculations, and challenges. Gut. 2001 Jan; 48(1):125-31. 1004734
    View PubMed
  350. Camilleri M. Novel medications for the irritable bowel syndrome: motility and sensation. J Pediatr Gastroenterol Nutr. 2001; 32 Suppl 1:S35-7. 1004851
    View PubMed
  351. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Progress in Geriatrics: Insights into the pathophysiology and mechanisms of constipation, IBS, and diverticulosis in the elderly. Am J Geriatr Soc. 2001. 1121472
  352. Camilleri M. Dyspepsia, irritable bowel syndrome, and constipation: review and what's new. Rev Gastroenterol Disord. 2001; 1(1):2-17. 1318413
    View PubMed
  353. Kim DY, Myung SJ, Camilleri M. Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol. 2000 Dec; 95(12):3365-73. 1014559
    View PubMed
  354. Camilleri M. Neurogastroenterology: evolving concepts and techniques to study motility and hypersensitivity. Digestive & Liver Disease. 2000 Dec; 32(Suppl 3):S227-32. 1014562
    View PubMed
  355. Camilleri M. Functional bowel disease: roles of sensation and motility. Schweiz Med Wochenschr. 2000 Nov 18; 130(46):1772-81. 1014540
    View PubMed
  356. Bharucha AE, Camilleri M, Haydock S, Ferber I, Burton D, Cooper S, Tompson D, Fitzpatrick K, Higgins R, Zinsmeister AR. Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans. Gut. 2000 Nov; 47(5):667-74. 139576
    View PubMed
  357. Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000 Oct 9; 160(18):2808-16. 139149
    View PubMed
  358. Coulie B, Camilleri M. New therapies for functional bowel diseases. Curr Gastroenterol Rep. 2000 Oct; 2(5):355-63. 1646916
    View PubMed
  359. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol. 2000 Oct; 95(10):2698-709. 139478
    View PubMed
  360. Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Choi MG, Nair KS, Verlinden M. Toward office-based measurement of gastric emptying in symptomatic diabetics using [13C]octanoic acid breath test. Am J Gastroenterol. 2000 Oct; 95(10):2751-61. 139479
    View PubMed
  361. Camilleri M, Lee JS, Viramontes B, Bharucha AE, Tangalos EG. Insights into the pathophysiology and mechanisms of constipation, irritable bowel syndrome, and diverticulosis in older people. J Am Geriatr Soc. 2000 Sep; 48(9):1142-50. 137151
    View PubMed
  362. Thumshirn M, Coulie B, Camilleri M, Zinsmeister AR, Burton DD, Van Dyke C. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2000 Jul; 14(7):869-78. 135014
    View PubMed
  363. Coulie B, Szarka LA, Camilleri M, Burton DD, McKinzie S, Stambler N, Cedarbaum JM. Recombinant human neurotrophic factors accelerate colonic transit and relieve constipation in humans. Gastroenterology. 2000 Jul; 119(1):41-50. 135442
    View PubMed
  364. Nehra V, Bruce BK, Rath-Harvey DM, Pemberton JH, Camilleri M. Psychological disorders in patients with evacuation disorders and constipation in a tertiary practice. Am J Gastroenterol. 2000 Jul; 95(7):1755-8. 136618
    View PubMed
  365. Lee JS, Camilleri M, Zinsmeister AR, Burton DD, Kost LJ, Klein PD. A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut. 2000 Jun; 46(6):768-73. 133660
    View PubMed
  366. Malcolm A, Camilleri M, Kost L, Burton DD, Fett SL, Zinsmeister AR. Towards identifying optimal doses for alpha-2 adrenergic modulation of colonic and rectal motor and sensory function. Alimentary Pharmacology & Therapeutics. 2000 Jun; 14(6):783-93. 133883
    View PubMed
  367. Samsom M, Szarka LA, Camilleri M, Vella A, Zinsmeister AR, Rizza RA. Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition. Am J Physiol Gastrointest Liver Physiol. 2000 Jun; 278(6):G946-51. 134150
    View PubMed
  368. Camilleri M, Williams DE. Economic burden of irritable bowel syndrome - proposed strategies to control expenditures. Pharmacoeconomics. 2000 Apr; 17(4):331-338. 131903
    View PubMed
  369. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000 Mar 25; 355(9209):1035-40. 131583
    View PubMed
  370. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology. 2000 Mar; 118(3):463-8. 130077
    View PubMed
  371. Malcolm A, Camilleri M. Coloanal motor coordination in association with high-amplitude colonic contractions after pharmacological stimulation. Am J Gastroenterol. 2000 Mar; 95(3):715-9. 130100
    View PubMed
  372. Camilleri M. Pharmacology and clinical experience with alosetron. Expert Opin Investig Drugs. 2000 Jan; 9(1):147-59. 1644620
    View PubMed
  373. Lee JS, Camilleri M. Image of the month. Gastroenterology. 2000; 119:614. 144470
  374. Camilleri M. Ten secrets for development of drugs for functional gastrointestinal diseases. Comments from the Editors Gastroenterology. 2000; 118:653. 146469
  375. Kellow JE, Delvaux MM, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: motility/sensation - sensation Rome II: The Functional Gastrointestinal Disorders, 2nd ed. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, eds. Lawrence, KS: Allen Press, Inc., 2000, pp. 91-156 2000. 146548
  376. Kuiken SD, Samsom M, Camilleri M, Mullan BP, Burton DD, Kost LJ, Hardyman TJ, Brinkmann BH, O'Connor MK. Development of a test to measure gastric accommodation in humans. Am J Physiol. 1999 Dec; 277(6 Pt 1):G1217-21. 126020
    View PubMed
  377. Camilleri M. Clinical subgroups of chronic constipation: exploring the potential of polyethylene glycol. Italian Journal of Gastroenterology & Hepatology. 1999 Nov; 31(Suppl 3):S253-4. 125382
  378. Camilleri M, Calobrisi SD. Skin eruptions in the diaper area. Curr Probl Dermatol. 1999 Nov-Dec; 11(6):213-244. 1010673
  379. Bouras EP, O'Brien TJ, Camilleri M, O'Connor MK, Mullan BP. Cerebral topography of rectal stimulation using single photon emission computed tomography. Am J Physiol. 1999 Sep; 277(3 Pt 1):G687-94. 1009370
    View PubMed
  380. Camilleri M, Mayer EA, Drossman DA, Heath A, Dukes GE, McSorley D, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999 Sep; 13(9):1149-59. 1010470
    View PubMed
  381. Kellow JE, Delvaux M, Azpiroz F, Camilleri M, Quigley EMM, Thompson DG. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut. 1999 Sep; 45(Suppl 2):17-24. 1010668
    View PubMed
  382. Bouras EP, Camilleri M, Burton DD, McKinzie S. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut. 1999 May; 44(5):682-6. 115067
    View PubMed
  383. Camilleri M. Review article: clinical evidence to support current therapies of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 1999 May; 13(Suppl 2):48-53. 117660
    View PubMed
  384. Mueller LA, Camilleri M, Emslie-Smith AM. Mitochondrial neurogastrointestinal encephalomyopathy: manometric and diagnostic features. Gastroenterology. 1999 Apr; 116(4):959-63. 110196
    View PubMed
  385. Thumshirn M, Camilleri M, Choi MG, Zinsmeister AR. Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology. 1999 Mar; 116(3):573-85. 109699
    View PubMed
  386. Mollen RM, Salvioli B, Camilleri M, Burton D, Kost LJ, Phillips SF, Pemberton JH. The effects of biofeedback on rectal sensation and distal colonic motility in patients with disorders of rectal evacuation: evidence of an inhibitory rectocolonic reflex in humans? Am J Gastroenterol. 1999 Mar; 94(3):751-6. 109849
    View PubMed
  387. Camilleri M. Motor function in irritable bowel syndrome. Can J Gastroenterol. 1999 Mar; 13(Suppl A):8A-11A. 117177
    View PubMed
  388. Scolapio JS, Camilleri M, Weckwerth JA, Romano M. Audit of the treatment of malnutrition due to chronic intestinal pseudo-obstruction with enteral nutrition. Nutr Clin Pract. 1999 Feb; 14(1):29-32. 1008974
  389. Harewood GC, Coulie B, Camilleri M, Rath-Harvey D, Pemberton JH. Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol. 1999 Jan; 94(1):126-30. 1314494
    View PubMed
  390. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut. 1999 Jan; 44(1):55-64. 109114
    View PubMed
  391. Forstner-Barthell AW, Murr MM, Nitecki S, Camilleri M, Prather CM, Kelly KA, Sarr MG. Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients. J Gastrointest Surg. 1999 Jan-Feb; 3(1):15-21, discussion 21-3. 123350
    View PubMed
  392. Camilleri M. Chronic intestinal pseudo-obstruction Approach to the Patient with Chronic Gastrointestinal Disorders. Corazziari E, ed. Millan: Messaggi srl, 1999:pp. 271-93. 146532
  393. Camilleri M. Review article: Functional bowel disease: a challenging frontier in gastroenterology. Maltese Medical Journal. 1999; 11:4-14. 146462
  394. Camilleri M. Therapeutic approach to the patient with irritable bowel syndrome. Am J Med. 1999; 107(5 Suppl 1):27-32. 126115
    View PubMed
  395. Coulie B, Camilleri M. Intestinal pseudo-obstruction. Annu Rev Med. 1999; 50:37-55. 109712
    View PubMed
  396. Maleki D, Camilleri M, Burton DD, Rath-Harvey DM, Oenning L, Pemberton JH, Low PA. Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci. 1998 Nov; 43(11):2373-8. 108496
    View PubMed
  397. Wagaman JR, Williams DE, Camilleri M. Behavioral intervention for the treatment of rumination. Journal of Pediatric Gastroenterology & Nutrition. 1998 Nov; 27(5):596-8. 108278
    View PubMed
  398. Camilleri M, Hasler WL, Parkman HP, Quigley EM, Soffer E. Measurement of gastrointestinal motility in the GI laboratory. Gastroenterology. 1998 Sep; 115(3):747-62. 107574
    View PubMed
  399. Thumshirn M, Camilleri M, Hanson RB, Williams DE, Schei AJ, Kammer PP. Gastric mechanosensory and lower esophageal sphincter function in rumination syndrome. Am J Physiol Gastrointest Liver Physiol. 1998 Aug; 275(2):G 314-G 321. 107341
  400. Weston S, Thumshirn M, Wiste J, Camilleri M. Clinical and upper gastrointestinal motility features in systemic sclerosis and related disorders. Am J Gastroenterol. 1998 Jul; 93(7):1085-9. 106541
    View PubMed
  401. Saslow SB, Scolapio JS, Camilleri M, Forstrom LA, Thomforde GM, Burton DD, Rubin J, Pitot HC, Zinsmeister AR. Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea. Gut. 1998 May; 42(5):628-34. 105473
    View PubMed
  402. Choi MG, Camilleri M, Burton DD, Johnson S, Edmonds A. Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. Journal of Pharmacology & Experimental Therapeutics. 1998 Apr; 285(1):37-40. 104508
    View PubMed
  403. Camilleri M, Ford MJ. Review article: colonic sensorimotor physiology in health, and its alteration in constipation and diarrhoeal disorders. Alimentary Pharmacology & Therapeutics. 1998 Apr; 12(4):287-302. 104979
    View PubMed
  404. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception - reproducibility and response to different distensions. Am J Physiol Gastrointest Liver Physiol. 1998 Mar; 274(3):G 584-G 590. 103932
  405. Mullan BP, Camilleri M, Hung JC. Activated charcoal as a potential radioactive marker for gastrointestinal studies. Nucl Med Commun. 1998 Mar; 19(3):237-40. 104460
    View PubMed
  406. Saslow SB, Thumshirn M, Camilleri M, Locke GR 3rd, Thomforde GM, Burton DD, Hanson RB. Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers. Dig Dis Sci. 1998 Feb; 43(2):258-64. 103899
    View PubMed
  407. Farrugia G, Nitecki S, Harty GJ, Camilleri M, Szurszewski JH. The effect of flufenamic acid on gastrointestinal myoelectrical activity and transit time in dogs. Gut. 1998 Feb; 42(2):258-65. 103334
    View PubMed
  408. Frank JW, Camilleri M, Thomforde GM, Dinneen SF, Rizza RA. Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans. Metabolism. 1998 Jan; 47(1):7-12. 103567
    View PubMed
  409. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol. 1998 Jan; 93(1):92-8. 103892
    View PubMed
  410. Camilleri M. Gastric emptying in diabetes mellitus: potential strategies to achieve euglycemia. Motility. 1998; issue 43:4-6. 146457
  411. Camilleri M. Gastrointestinal motility disorders. Scientific American Medicine. Dale DC, Federman DD, eds. New York: Scientific American Medicine Publishers, 1998. 146514
  412. Camilleri M, Maleki D, Barnett D. Gastrointestinal complications of diabetes mellitus. The Uncomplicated Guide to Diabetes Complications. Levin ME, Pfeiffer MA, eds. Alexandria, VA: American Diabetes Association, 1998:pp. 236-49. 146524
  413. Camilleri M. Motor function in functional dyspepsia and irritable bowel syndrome. Functional Dyspepsia and Irritable bowel syndrome: Concepts and Controversies. Goebell H, Holtmann G, Talley N, eds. Lancaster, U.K.: Kluwer Academic Publishers, 1998:pp 103-12. 146529
  414. Fujimura J, Camilleri M, Low PA, Novak V, Novak P, Opfer-Gehrking TL. Effect of perturbations and a meal on superior mesenteric artery flow in patients with orthostatic hypotension. J Auton Nerv Syst. 1997 Dec 3; 67(1-2):15-23. 101291
    View PubMed
  415. Saslow SB, O'Brien MD, Camilleri M, von der Ohe M, Homburger HA, Klee GG, Pitot HC, Rubin J. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome. Am J Gastroenterol. 1997 Dec; 92(12):2250-6. 101133
    View PubMed
  416. Burton DD, Camilleri M, Mullan BP, Forstrom LA, Hung JC. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med. 1997 Nov; 38(11):1807-10. 100903
    View PubMed
  417. Malcolm A, Phillips SF, Camilleri M, Hanson RB. Pharmacological modulation of rectal tone alters perception of distention in humans. Am J Gastroenterol. 1997 Nov; 92(11):2073-9. 100855
    View PubMed
  418. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol Gastrointest Liver Physiol. 1997 Nov; 273(5):G 997-G1006. 100917
  419. Bharucha AE, Novak V, Camilleri M, Zinsmeister AR, Hanson RB, Low PA. Alpha (2)-adrenergic modulation of colonic tone during hyperventilation. Am J Physiol Gastrointest Liver Physiol. 1997 Nov; 273(5):G1135-G1140. 100919
  420. Scolapio JS, Camilleri M, Fleming CR, Oenning LV, Burton DD, Sebo TJ, Batts KP, Kelly DG. Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study. Gastroenterology. 1997 Oct; 113(4):1074-81. 100416
    View PubMed
  421. Maleki D, Camilleri M, Zinsmeister AR, Rizza RA. Effect of acute hyperglycemia on colorectal motor and sensory function in humans. Am J Physiol Gastrointest Liver Physiol. 1997 Oct; 273(4):G 859-G 864. 100614
  422. Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol. 1997 Sep; 92(9):1496-500. 100133
    View PubMed
  423. Malcolm A, Thumshirn MB, Camilleri M, Williams DE. Rumination syndrome. Mayo Clin Proc. 1997 Jul; 72(7):646-52. 99071
    View PubMed
  424. Scolapio JS, Camilleri M, Fleming CR. Gastrointestinal motility considerations in patients with short-bowel syndrome. Dig Dis. 1997 Jul-Oct; 15(4-5):253-62. 100617
    View PubMed
  425. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology. 1997 Jun; 112(6):2120-37. 98959
    View PubMed
  426. Bruninga K, Camilleri M. Colonic motility and tone after spinal cord and cauda equina injury. Am J Gastroenterol. 1997 May; 92(5):891-4. 102435
    View PubMed
  427. Choi MG, Camilleri M, Burton DD, Zinsmeister AR, Forstrom LA, Nair KS. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology. 1997 Apr; 112(4):1155-62. 102149
    View PubMed
  428. Charles F, Phillips SF, Camilleri M, Thomforde GM. Rapid gastric emptying in patients with functional diarrhea. Mayo Clin Proc. 1997 Apr; 72(4):323-8. 98733
    View PubMed
  429. Nguyen A, Camilleri M, Kost LJ, Metzger A, Sarr MG, Hanson RB, Fett SL, Zinsmeister AR. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther. 1997 Mar; 280(3):1270-6. 101911
    View PubMed
  430. Camilleri M, Choi MG. Irritable bowel syndrome. Aliment Pharmacol Ther. 1997 Feb; 11(1):3-15. 101774
    View PubMed
  431. Choi MG, Camilleri M, O'Brien MD, Kammer PP, Hanson RB. A pilot study of motility and tone of the left colon in patients with diarrhea due to functional disorders and dysautonomia. Am J Gastroenterol. 1997 Feb; 92(2):297-302. 101739
    View PubMed
  432. Loftus EV Jr, Farrugia G, Donohue JH, Camilleri M. Duodenal obstruction: diagnosis by gastroduodenal manometry. Mayo Clin Proc. 1997 Feb; 72(2):130-2. 102135
    View PubMed
  433. O'Brien MD, Camilleri M, Thomforde GM, Wiste JA, Hanson RB, Zinsmeister AR. Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit. Dig Dis Sci. 1997 Jan; 42(1):26-33. 101633
    View PubMed
  434. Camilleri M. Diarrhea and irritable bowel syndrome: Practical approaches. Surgery and Colon & Rectum. Nicholls RJ, Dozois RR, eds. London: Churchill Livingstone, 1997:pp. 681-689. 146537
  435. Camilleri M. Dysautonomic findings in functional gastrointestinal disorders. Functional Dyspepsia. Mearin F, ed. Barcelona, Spain: Doyma Publishers, 1997:pp. 133-138. 146545
  436. Whitehead WE, Delvaux M, Azpiroz F, Barlow J, Bradley L, Camilleri M, Crowell MD, Enck P, Fioramonti J, Janssens J, Mayer EA, Morteau O, Phillips SF, Thompson DG, Wingate DL. Standardization of procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci. 1997; 42:223-41. 1648632
    View PubMed
  437. O'Brien MD, Camilleri M, von der Ohe MR, Phillips SF, Pemberton JH, Prather CM, Wiste JA, Hanson RB. Motility and tone of the left colon in constipation: a role in clinical practice? Am J Gastroenterol. 1996 Dec; 91(12):2532-8. 98343
    View PubMed
  438. Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol. 1996 Sep; 16(3):203-16. 98609
    View PubMed
  439. Bharucha AE, Camilleri M, Ford MJ, O'Connor MK, Hanson RB, Thomforde GM. Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology. 1996 Aug; 111(2):368-77. 97415
    View PubMed
  440. Ford MJ, Camilleri M, Joyner MJ, Hanson RB. Autonomic control of colonic tone and the cold pressore test. Gut. 1996 Jul; 39(1):125-9. 96683
    View PubMed
  441. Camilleri M, Balm RK, Zinsmeister AR. Symptomatic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility. Alimentary Pharmacology & Therapeutics. 1996 Jun; 10(3):403-9. 95776
    View PubMed
  442. Camilleri M. Nonulcer dyspepsia: a look into the future. Mayo Clin Proc. 1996 Jun; 71(6):614-22. 95716
    View PubMed
  443. Camilleri M. Gastrointestinal problems in diabetes. Endocrinology & Metabolism Clinics of North America. 1996 Jun; 25(2):361-78. 95733
    View PubMed
  444. Zein NN, Perrault J, Camilleri M. Recurrent vomiting following Harrington rod instrumentation of the spine. Journal of Pediatric Gastroenterology & Nutrition. 1996 Apr; 22(3):318-20. 95974
    View PubMed
  445. Surrenti E, Camilleri M, Kammer PP, Prather CM, Schei AJ, Hanson RB. Antral axial forces postprandially and after erythromycin in organic and functional dysmotilities. Dig Dis Sci. 1996 Apr; 41(4):697-704. 96067
    View PubMed
  446. Farrugia G, Camilleri M, Whitehead WE. Therapeutic strategies for motility disorders. Medications, nutrition, biofeedback, and hypnotherapy. Gastroenterol Clin North Am. 1996 Mar; 25(1):225-46. 95957
    View PubMed
  447. Camilleri M, Saslow SB, Bharucha AE. Gastrointestinal sensation. Mechanisms and relation to functional gastrointestinal disorders. Gastroenterol Clin North Am. 1996 Mar; 25(1):247-58. 95958
    View PubMed
  448. Scolapio JS, Camilleri M. Nonulcer dyspepsia. Gastroenterologist. 1996 Mar; 4(1):13-23. 97833
    View PubMed
  449. Saslow SB, Camilleri M, Thomforde GM, Van Dyke CT, Pitot HC, Rubin J. Relation between fat malabsorption and transit abnormalities in human carcinoid diarrhea. Gastroenterology. 1996 Feb; 110(2):405-10. 95624
    View PubMed
  450. Camilleri M. Effect of altered control of the autonomic nervous system on gastrointestinal function. Proceedings of the International Symposium of NeuroGastroenterology. Corazziari E, ed. Berlin: Walter De Gruyter & Co., 1996:pp. 187-198. 146539
  451. Camilleri M, Saslow SB. Somatostatin analogs in the treatment of gastrointestinal motility disorders Advances in Gastroenterology Hepatology & Clinical Nutrition , 1996; 1:291-8. 145548
  452. Camilleri M. Gastrointestinal neuropathies relieved by prokinetic therapy Gastroenterology Observer. 1996; 15:2-3. 145546
  453. Camilleri M. Effects of somatostatin analogues on human gastrointestinal motility. Digestion. 1996; 57(Suppl 1):90-2. 96447
    View PubMed
  454. Talley NJ, Camilleri M. Epidemiological features of functional dyspepsia and irritable bowel syndrome. Clinican. 1996; 14:7-13. 1346408
  455. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology. 1995 Dec; 109(6):1772-80. 91193
    View PubMed
  456. Murr MM, Sarr MG, Camilleri M. The surgeon's role in the treatment of chronic intestinal pseudoobstruction. Am J Gastroenterol. 1995 Dec; 90(12):2147-51. 91124
    View PubMed
  457. Saslow SB, Camilleri M. Diabetic diarrhea. Semin Gastrointest Dis. 1995 Oct; 6(4):187-93. 94162
    View PubMed
  458. Rowe FA, Camilleri M, Forstrom LA, Batts KP, Mullan BP, Thomforde GM, Dunn W, Zinsmeister AR. A pilot study of splenic and whole body retention of autologous radiolabeled leukocytes in the assessment of severity in inflammatory colitis. Am J Gastroenterol. 1995 Oct; 90(10):1771-5. 93935
    View PubMed
  459. Ford MJ, Camilleri MJ, Hanson RB, Wiste JA, Joyner MJ. Hyperventilation, central autonomic control, and colonic tone in humans. Gut. 1995 Oct; 37(4):499-504. 93850
    View PubMed
  460. Frank JW, Saslow SB, Camilleri M, Thomforde GM, Dinneen S, Rizza RA. Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology. 1995 Sep; 109(3):755-65. 93779
    View PubMed
  461. Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol. 1995 Sep; 90(9):1471-5. 93739
    View PubMed
  462. Ford MJ, Camilleri M, Wiste JA, Hanson RB. Differences in colonic tone and phasic response to a meal in the transverse and sigmoid human colon. Gut. 1995 Aug; 37(2):264-9. 93482
    View PubMed
  463. Camilleri M. Gastrointestinal manifestations of diabetes mellitus. (Overview). Eur J Gastroenterol Hepatol. 1995 Aug; 7:709-710. 93725
  464. Singaram C, Sweet MA, Gaumnitz EA, Cameron AJ, Camilleri M. Peptidergic and nitringergic denervation in congenital esophageal stenosis. (Note). Gastroenterology. 1995 Jul; 109:275-281. 92936
    View PubMed
  465. Scolapio JS, Camilleri M, von der Ohe MR, Hanson RB. Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism. Scand J Gastroenterol. 1995 Jun; 30(6):562-7. 93040
    View PubMed
  466. Gaspari JC, Sande JR, Thomas CF Jr, Zighelboim J, Camilleri M. Lupus anticoagulant masquerading as an acute abdomen with multiorgan involvement. Am J Gastroenterol. 1995 May; 90(5):825-6. 92708
    View PubMed
  467. Forstrom LA, Dunn WL, Rowe FA, Camilleri M. In-111-oxine-labelled granulocyte dosimetry in normal subjects. Nucl Med Commun. 1995 May; 16:349-356. 92666
    View PubMed
  468. von der Ohe MR, Camilleri M, Thomforde GM, Klee GG. Differential regional effects of octreotide on human gastrointestinal motor function. Gut. 1995 May; 36(5):743-8. 92656
    View PubMed
  469. Pemberton JH, Camilleri M, Fleshman JW. Clinical management of the constipated patient. Ann Intern Med. 1995 Apr 15; 122:632. 1023350
  470. O'Brien MD, Bruce BK, Camilleri M. The rumination syndrome: clinical features rather than manometric diagnosis. Gastroenterology. 1995 Apr; 108(4):1024-9. 92249
    View PubMed
  471. Charles F, Camilleri M, Phillips SF, Thomforde GM, Forstrom LA. Scintigraphy of the whole gut: clinical evaluation of transit disorders. Mayo Clin Proc. 1995 Feb; 70(2):113-8. 91585
    View PubMed
  472. Thomforde GM, Camilleri M, Phillips SF, Forstrom LA. Evaluation of an inexpensive screening scintigraphic test of gastric emptying. J Nucl Med. 1995 Jan; 36(1):93-6. 91795
    View PubMed
  473. Camilleri M. Irritable bowel syndrome: the pathophysiologic links to more effective future therapy Participate Practical Gastroenterology (reprint), 1316-18, 1999 1995; 4:1-2. 145544
  474. Camilleri M. The management of chronic intestinal psuedo-obstruction Motility. 1995; 30:7-10. 144744
  475. Camilleri M, Ford M, Bharucha A, Hanson R, Zinsmeister A. Psychosensory and autonomic modulation of colonic sensation in healthy humans. Third International Symposium on Brain-Gut Interactions Cambridge, UK, July 19-22, 1995. 1121304
  476. Low PA, Opfer-Gehrking TL, Textor SC, Schondorf R, Suarez GA, Fealey RD, Camilleri M. Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst. 1994 Dec 15; 50(2):181-8. 89591
    View PubMed
  477. Camilleri M, Prather CM. Axial forces during gastric emptying in health and models of disease. Dig Dis Sci. 1994 Dec; 39(Suppl S):S14-S17. 90302
    View PubMed
  478. Camilleri M, Thompson WG, Fleshman JW, Pemberton JH. Clinical management of intractable constipation. Ann Intern Med. 1994 Oct 1; 121(7):520-8. 90150
    View PubMed
  479. Camilleri M. Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility. Am J Gastroenterol. 1994 Oct; 89(10):1769-74. 90246
    View PubMed
  480. von der Ohe MR, Camilleri M, Carryer PW. A patient with localized megacolon and intractable constipation: evidence for impairment of colonic muscle tone. Am J Gastroenterol. 1994 Oct; 89(10):1867-70. 90248
    View PubMed
  481. Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994 Sep; 44(9):1675-82. 88905
    View PubMed
  482. Vonderohe MR, Hanson RB, Camilleri M. Comparison of simultaneous recordings of human colonic contractions by manometry and a barostat. Neurogastroenterol Motil. 1994 Sep; 6:213-222. 88979
  483. Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut. 1994 Aug; 35(8):1064-9. 89117
    View PubMed
  484. Camilleri M, Von der Ohe MR. Drugs affecting serotonin receptors. Baillieres Clin Gastroenterol. 1994 Jun; 8(2):301-19. 88556
    View PubMed
  485. Vonderohe MR, Camilleri M, Kvols LK. A 5HT(3) antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology. 1994 May; 106:1184-1189. 88236
    View PubMed
  486. Camilleri M. Human gastroduodenojejunal manometry. Dig Dis Sci. 1994 May; 39:1149-1150. 1033751
  487. Camilleri M, Balm RK, Zinsmeister AR. Determinants of response to a prokinetic agent in neuropathic chronic intestinal motility disorder. Gastroenterology. 1994 Apr; 106(4):916-23. 87387
    View PubMed
  488. von der Ohe MR, Hanson RB, Camilleri M. Serotonergic mediation of postprandial colonic tonic and phasic responses in humans. Gut. 1994 Apr; 35(4):536-41. 88316
    View PubMed
  489. Camilleri M. Small bowel motility disorders. Rev Gastroenterol Mex. 1994 Apr-Jun; 59(2):120-6. 90446
    View PubMed
  490. Frank JW, Sarr MG, Camilleri M. Use of gastroduodenal manometry to differentiate mechanical and functional intestinal obstruction: an analysis of clinical outcome. Am J Gastroenterol. 1994 Mar; 89(3):339-44. 88254
    View PubMed
  491. Camilleri M. Atlas of Gastrointestinal Motility in Health and Disease Gastroenterology ( 1994; Book review). 145537
  492. Valdovinos MA, Camilleri M, Thomforde GM, Frie C. Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal mobility disorders. Scand J Gastroenterol. 1993 Nov; 28:963-968. 1030394
    View PubMed
  493. Von Der Ohe M, Camilleri M, Zimmerman BR. Management of diabetic enteropathy. Endocrinologist. 1993 Nov; 3:400-408. 85265
  494. von der Ohe MR, Camilleri M, Kvols LK, Thomforde GM. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med. 1993 Oct 7; 329(15):1073-8. 84754
    View PubMed
  495. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 1993 Oct; 7(5):543-51. 84660
    View PubMed
  496. Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc. 1993 Jul; 68(7):691-702. 83746
    View PubMed
  497. Badley AD, Camilleri M, O'Connor MK. Noninvasive measurement of human ascending colon volume. Nucl Med Commun. 1993 Jun; 14(6):485-9. 85647
    View PubMed
  498. Aggarwal AM, Camilleri M, Phillips SF, Schlagheck TG, Brown ML, Thomforde GM. Olestra, a nondigestible, nonabsorbable fat. Effects on gastrointestinal and colonic transit. Dig Dis Sci. 1993 Jun; 38(6):1009-14. 85643
    View PubMed
  499. Oosterbosch L, von der Ohe M, Valdovinos MA, Kost LJ, Phillips SF, Camilleri M. Effects of serotonin on rat ileocolonic transit and fluid transfer in vivo: possible mechanisms of action. Gut. 1993 Jun; 34(6):794-8. 85644
    View PubMed
  500. Prather CM, Camilleri M, Thomforde GM, Forstrom LA, Zinsmeister AR. Gastric axial forces in experimentally delayed and accelerated gastric emptying. Am J Physiol. 1993 May; 264(5 Pt 1):G928-34. 83719
    View PubMed
  501. Camilleri M. Study of human gastroduodenojejunal motility. Dig Dis Sci. 1993 May; 38:785-794. 83371
    View PubMed
  502. Camilleri M, Balm RK, Low PA. Autonomic dysfunction in patients with chronic intestinal pseudo-obstruction. Clin Auton Res. 1993 Apr; 3(2):95-100. 85270
    View PubMed
  503. Bharucha AE, Camilleri M, Low PA, Zinsmeister AR. Autonomic dysfunction in gastrointestinal motility disorders. Gut. 1993 Mar; 34(3):397-401. 85272
    View PubMed
  504. Hammer J, Camilleri M, Phillips SF, Aggarwal A, Haddad AM. Does the ileocolonic junction differentiate between solids and liquids? Gut. 1993 Feb; 34(2):222-6. 1313886
    View PubMed
  505. Leighton JA, Valdovinos MA, Pemberton JH, Rath DM, Camilleri M. Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis. Dis Colon Rectum. 1993 Feb; 36(2):182-5. 83410
    View PubMed
  506. Valdovinos MA, Thomforde GM, Camilleri M. Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5-HT receptors. Aliment Pharmacol Ther. 1993 Feb; 7(1):61-6. 85646
    View PubMed
  507. Camilleri M. Four patients with intractable constipation. Gastrointestinal Diseases Today. 1993; 2:7-15. 85648
  508. von der Ohe MR, Camilleri M. Measurement of small bowel and colonic transit: indications and methods. Mayo Clin Proc. 1992 Dec; 67(12):1169-79. 81015
    View PubMed
  509. Miedema BW, Kelly KA, Camilleri M, Hanson RB, Zinsmeister AR, O'Connor MK, Brown ML. Human gastric and jejunal transit and motility after Roux gastrojejunostomy. Gastroenterology. 1992 Oct; 103(4):1133-43. 80649
    View PubMed
  510. Fich A, Steadman CJ, Phillips SF, Camilleri M, Brown ML, Haddad AC, Thomforde GM. Ileocolonic transit does not change after right hemicolectomy. Gastroenterology. 1992 Sep; 103(3):794-9. 80475
    View PubMed
  511. Vassallo MJ, Camilleri M, Phillips SF, Steadman CJ, Talley NJ, Hanson RB, Haddad AC. Colonic tone and motility in patients with irritable bowel syndrome. Mayo Clin Proc. 1992 Aug; 67(8):725-31. 80355
    View PubMed
  512. Vassallo MJ, Camilleri M, Prather CM, Hanson RB, Thomforde GM. Measurement of axial forces during emptying from the human stomach. Am J Physiol. 1992 Aug; 263(2 Pt 1):G230-9. 1313800
    View PubMed
  513. Camilleri M, Prather CM, Evans MA, Andresen-Reid ML. Balance studies and polymeric glucose solution to optimize therapy after massive intestinal resection. Mayo Clin Proc. 1992 Aug; 67(8):755-60. 1313782
    View PubMed
  514. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology. 1992 Jul; 103(1):36-42. 80224
    View PubMed
  515. Ruytjens I, Thomforde GM, Camilleri M, Chapman NJ. Effect of chemical sympathectomy on scintigraphic gastric and small bowel transit in the rat. J Auton Nerv Syst. 1992 Jun 15; 39(2):111-7. 80220
    View PubMed
  516. Camilleri M, Prather CM. The irritable bowel syndrome: mechanisms and a practical approach to management. Ann Intern Med. 1992 Jun 15; 116(12 Pt 1):1001-8. 80120
    View PubMed
  517. Stark ME, Camilleri M, Fitzpatrick LA, Van Heerden JA. A 47-year-old woman with chronic constipation, hypercalcemia, and pulmonary nodule. Gastroenterology. 1992 Jun; 5:115-125. 82316
  518. Steadman CJ, Phillips SF, Camilleri M, Talley NJ, Haddad A, Hanson R. Control of muscle tone in the human colon. Gut. 1992 Apr; 33(4):541-6. 79862
    View PubMed
  519. Vassallo MJ, Camilleri M, Sullivan SN, Thomforde GM. Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol. 1992 Apr; 14(3):255-9. 81525
    View PubMed
  520. Vassallo M, Camilleri M, Phillips SF, Brown ML, Chapman NJ, Thomforde GM. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology. 1992 Jan; 102(1):102-8. 1313780
    View PubMed
  521. Prather CM, Camilleri M. Medical management of small bowel motility disorders and chronic intestinal pseudo-obstruction. Pract Gastroenterol. 1992; 16:25-37. 1313787
  522. Camilleri M. Targeting therapy for the irritable bowel syndrome. Med Actual. 1992; 28:581-589. 81532
  523. Layer P, Camilleri M. Erbrechan Gastroenterologie Vol 10 Goebell H(ed) Innere Medizine de Gegenwart Munchen, Wien, & Schwarzenberg, , pp 87-92 1992; Baltimore:Urban. 146479
  524. Layer P, Berges F-W, Camilleri M, Ihe M v d Erckenbrecht JF. Untersuchungen der motilitat und des transits Gastroenterologie Vol 10 Goebell H (ed) Innere Medizin der Gegenwart Munchen, Wien, & Schwarzenberg, , pp 186-203 1992; Baltimore:Urban. 146482
  525. Camilleri M, Carbone LD, Schuffler MD. Familial enteric neuropathy with pseudoobstruction. Dig Dis Sci. 1991 Aug; 36(8):1168-71. 78274
    View PubMed
  526. Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterology. 1991 Aug; 101(2):373-81. 78271
    View PubMed
  527. Stivland T, Camilleri M, Vassallo M, Proano M, Rath D, Brown ML, Thomforde G, Pemberton JH, Phillips SF. Scintigraphic measurement of regional gut transit idiopathic constipation. Gastroenterology. 1991 Jul; 101:107-115. 76684
    View PubMed
  528. Camilleri M, Vassallo M. Small intestinal motility and transit in disease. Baillieres Clin Gastroenterol. 1991 Jun; 5(2):431-51. 76958
    View PubMed
  529. Phillips SF, Camilleri M. The ileocecal area and the irritable bowel syndrome. Gastroenterol Clin North Am. 1991 Jun; 20(2):297-311. 76653
    View PubMed
  530. Camilleri M, Zinsmeister AR, Greydanus MP, Brown ML, Proano M. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci. 1991 May; 36(5):609-15. 76698
    View PubMed
  531. Abell TL, Camilleri M, DiMagno EP, Hench VS, Zinsmeister AR, Malagelada JR. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci. 1991 May; 36(5):616-20. 76699
    View PubMed
  532. Greydanus MP, Vassallo M, Camilleri M, Nelson DK, Hanson RB, Thomforde GM. Neurohormonal factors in functional dyspepsia: insights on pathophysiological mechanisms. Gastroenterology. 1991 May; 100(5 Pt 1):1311-8. 76539
    View PubMed
  533. Abell TL, Camilleri M, Hench VS, Malagelada JR. Gastric electromechanical function and gastric emptying in diabetic gastroparesis. Eur J Gastroenterol Hepatol. 1991 Feb; 3:163-167. 76193
  534. Vassallo M, Camilleri M, Caron BL, Low PA. Gastrointestinal motor dysfunction in acquired selective cholinergic dysautonomia associated with infectious mononucleosis. Gastroenterology. 1991 Jan; 100(1):252-8. 78220
    View PubMed
  535. Lennon VA, Sas DF, Busk MF, Scheithauer B, Malagelada JR, Camilleri M, Miller LJ. Enteric neuronal autoantibodies in pseudoobstruction with small-cell lung carcinoma. Gastroenterology. 1991 Jan; 100(1):137-42. 78269
    View PubMed
  536. Sandborn WJ, Camilleri M. Laboratory investigation in inflammatory bowel disease. Pract Gastroenterol. 1991; 15:11-15. 79048
  537. Proano M, Camilleri M, Phillips SF, Thomforde GM, Brown ML, Tucker RL. The unprepared human colon does not discriminate between solids and liquids. Am J Physiol. 1991; (260):G13-G16. 78270
  538. Kelly DG, Camilleri M. Gastrointestinal motility. Support Line. 1991; 13:7-10. 78272
  539. Camilleri M. A guide to the treatment of GI motility disorders. Drug Therapy. 1991; 21:15-28. 78273
    View PubMed
  540. Camilleri M. Medical treatment of chronic intestinal pseudo-obstruction. Pract Gastroenterol. 1991; 15:10-22. 78268
  541. Kim CH, Kennedy FP, Camilleri M, Zinsmeister AR, Ballard DJ. The relationship between clinical factors and gastrointestinal dysmotility in diabetes mellitus. Journal of Gastrointestinal Motility. 1991; 3:268-272. 78275
  542. Camilleri M, Phillips SF. Acute and chronic intestinal pseudo-obstruction. Adv Intern Med. 1991; 36:287-306. 76186
    View PubMed
  543. Thomforde GM, Malagelada JR, Camilleri M, Yaksh TL. Demonstration of intrathecal and systemic morphine and ST-91 effects on fed canine upper gut motility. Dig Dis Sci. 1990 Oct; 35(10):1249-56. 73614
    View PubMed
  544. Fich A, Neri M, Camilleri M, Kelly KA, Phillips SF. Stasis syndromes following gastric surgery: clinical and motility features of 60 symptomatic patients. J Clin Gastroenterol. 1990 Oct; 12(5):505-12. 107027
    View PubMed
  545. Greydanus MP, Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM. Ileocolonic transfer of solid chyme in small intestinal neuropathies and myopathies. Gastroenterology. 1990 Jul; 99(1):158-64. 72777
    View PubMed
  546. Proano M, Camilleri M, Phillips SF, Brown ML, Thomforde GM. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am J Physiol. 1990 Jun; 258(6 Pt 1):G856-62. 72989
    View PubMed
  547. Camilleri M. Disorders of gastrointestinal motility in neurologic diseases. Mayo Clin Proc. 1990 Jun; 65(6):825-46. 72970
    View PubMed
  548. Camilleri M, Fealey RD. Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal diseases: a causal association? Dig Dis Sci. 1990; 35:609-616. 75038
    View PubMed
  549. Sodhi N, Camilleri M, Camoriano JK, Low PA, Fealey RD, Perry MC. Autonomic function and motility in intestinal pseudoobstruction caused by paraneoplastic syndrome. Dig Dis Sci. 1989 Dec; 34(12):1937-42. 70429
    View PubMed
  550. Camilleri M, Neri M. Motility disorders and stress. Dig Dis Sci. 1989 Nov; 34(11):1777-86. 70134
    View PubMed
  551. Talley NJ, Camilleri M, Orkin BA, Kramlinger KG. Effect of cyclical unipolar depression on upper gastrointestinal motility and sleep. Gastroenterology. 1989 Sep; 97(3):775-7. 71421
    View PubMed
  552. Fich A, Camilleri M, Phillips SF. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol. 1989 Aug; 11(4):416-20. 69480
    View PubMed
  553. Barbara L, Camilleri M, Corinaldesi R, Crean GP, Heading RC, Johnson AG, Malagelada JR, Stanghellini V, Wienbeck M. Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci. 1989 Aug; 34(8):1272-6. 69559
    View PubMed
  554. Camilleri M, Colemont LJ, Phillips SF, Brown ML, Thomforde GM, Chapman N, Zinsmeister AR. Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol. 1989 Aug; 257(2 Pt 1):G284-90. 69587
    View PubMed
  555. Camilleri M, Proano M. Advances in the assessment of disease activity in inflammatory bowel disease. Mayo Clin Proc. 1989 Jul; 64(7):800-7. 69643
    View PubMed
  556. Camilleri M, Phillips SF. Disorders of small intestinal motility. Gastroenterol Clin North Am. 1989 Jun; 18(2):405-24. 69380
    View PubMed
  557. Camilleri M. Jejunal manometry in distal subacute mechanical obstruction: significance of prolonged simultaneous contractions. Gut. 1989 Apr; 30(4):468-75. 69203
    View PubMed
  558. Camilleri M, Malagelada JR, Abell TL, Brown ML, Hench V, Zinsmeister AR. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology. 1989 Mar; 96(3):704-12. 68618
    View PubMed
  559. Colemont LJ, Camilleri M. Subspecialty clinics: gastroenterology. Chronic intestinal pseudo-obstruction: diagnosis and treatment. Mayo Clin Proc. 1989 Jan; 64:60-70. 68498
    View PubMed
  560. Greydanus MP, Camilleri M. Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis. Gastroenterology. 1989 Jan; 96(1):110-5. 68410
    View PubMed
  561. Camilleri M. Chronic intestinal pseudo-obstruction: new approaches in diagnosis and treatment. Investigation and Treatment of Upper Gastrointestinal Motility Disorders Proceedings of a symposium held in Ottawa, Canada Publishing Foundation, , pp 19-26 1988; Toronto:The Medicine. 146476
  562. Abell TL, Malagelada JR, Lucas AR, Brown ML, Camilleri M, Go VL, Azpiroz F, Callaway CW, Kao PC, Zinsmeister AR. Gastric electromechanical and neurohormonal function in anorexia nervosa. Gastroenterology. 1987 Nov; 93(5):958-65. 1313217
    View PubMed
  563. Shetty N, Camilleri M, Moss DW, Hodgson HJ. Subtle hyperthyroidism presenting as suspected hepatobiliary disease. J Clin Gastroenterol. 1987 Apr; 9(2):186-8. 63639
    View PubMed
  564. Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut. 1987 Jan; 28(1):5-12. 61475
    View PubMed
  565. Camilleri M. Clinical gastroenterology in Malta. Malta: Printex Publishers; 1987. 63644
  566. Vassallo M, Camilleri M. Monoclonal protein amyloidosis presenting with hepatomegaly Clinical Gastroenterology in Malta Camiller M ed Publishers Printex Malta, , pp77-81 1987. 146472
  567. Camilleri M. AIDS diagnosis and control: report on the current situation in Malta, March 1987. AIDS Diagnosis and Report of a WHO meeting held in Munich March 16-18, Koch MA, Deinhardt F, eds Munich MMV Medizin Verlag, 1988, pp 139-140 1987; Control:Current Situation. 146478
  568. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci. 1986 Nov; 31:1169-1177. 59773
    View PubMed
  569. Camilleri M, Brown ML, Malagelada JR. Impaired transit of chyme in chronic intestinal pseudoobstruction. Correction by cisapride. Gastroenterology. 1986 Sep; 91(3):619-26. 58937
    View PubMed
  570. Camilleri M, Thompson DG, Malagelada JR. Functional dyspepsia. Symptoms and underlying mechanism. J Clin Gastroenterol. 1986 Aug; 8(4):424-9. 58997
    View PubMed
  571. Camilleri M, Malagelada JR, Stanghellini V, Zinsmeister AR, Kao PC, Li CH. Dose-related effects of synthetic human beta-endorphin and naloxone on fed gastrointestinal motility. Am J Physiol. 1986 Jul; 251(1 Pt 1):G147-54. 58784
    View PubMed
  572. Camilleri M, Brown ML, Malagelada JR. Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology. 1986 Jul; 91(1):94-9. 58622
    View PubMed
  573. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986 Jun; 90(6):1919-25. 58512
    View PubMed
  574. Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology. 1986 May; 90(5 Pt 1):1121-8. 60061
    View PubMed
  575. Camilleri M, Mearin F. Evaluation of gastric motility disorders by gastrointestinal manometry and radioscintigraphic gastric emptying studies. Gastrum. 1986 Apr; 34-40. 60062
  576. Mearin F, Camilleri M. Diabetic gastroparesis. Gastrum. 1986 Apr; 40-5. 60063
  577. Camilleri M. Alimentary tract and pancreas. New approaches to the diagnosis of functional upper gut disease. J Gastroenterol Hepatol. 1986; 1:273-279. 60064
  578. Wood JR, Camilleri M, Low PA, Malagelada JR. Brainstem tumor presenting as an upper gut motility disorder. Gastroenterology. 1985 Dec; 89(6):1411-4. 56004
    View PubMed
  579. Camilleri M, Malagelada JR, Brown ML, Becker G, Zinsmeister AR. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol. 1985 Nov; 249(5 Pt 1):G580-5. 56076
    View PubMed
  580. Camilleri M, Malagelada JR, Stanghellini V, Fealey RD, Sheps SG. Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology. 1985 Jun; 88(6):1852-9. 54940
    View PubMed
  581. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest. 1984 Dec; 14(6):420-7. 52968
    View PubMed
  582. Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Effect of somatovisceral reflexes and selective dermatomal stimulation on postcibal antral pressure activity. Am J Physiol. 1984 Dec; 247(6 Pt 1):G703-8. 52973
    View PubMed
  583. Malagelada JR, Camilleri M. Unexplained vomiting: a diagnostic challenge. Ann Intern Med. 1984 Aug; 101(2):211-8. 51949
    View PubMed
  584. Camilleri M, Chadwick VS, Hodgson HJ. Vascular anomalies of the gastrointestinal tract. Hepatogastroenterology. 1984 Jun; 31(3):149-53. 53352
    View PubMed
  585. Camilleri M, Victorino RM, Hodgson HJ. Halothane aggravation of chronic liver disease. Acta Med Port. 1984 Jun; 5(6):194-6. 53353
    View PubMed
  586. Cox TM, O'Donnell MW, Camilleri M. Allelic heterogeneity in adult hereditary fructose intolerance. Detection of structural mutations in the aldolase B molecule. Mol Biol Med. 1983 Nov; 1(4):393-400. 50165
    View PubMed
  587. Camilleri M, Krausz T, Lewis PD, Hodgson HJ, Pallis CA, Chadwick VS. Malignant histiocytosis and encephalomyeloradiculopathy complicating coeliac disease. Gut. 1983 May; 24(5):441-7. 1312756
    View PubMed
  588. Camilleri M, Pusey CD, Chadwick VS, Rees AJ. Gastrointestinal manifestations of systemic vasculitis. Q J Med. 1983 Spring; 52(206):141-9. 50160
    View PubMed
  589. Cox TM, O'Donnell MW, Sochor M, Camilleri M, McLean P. Hereditary fructose intolerance: presence of a potent inhibitor of fructose-1-phosphate aldolase in the liver. Biochem Soc Trans. 1983; 11:202-203. 50161
  590. Cox TM, O'Donnell MW, Camilleri M, Burghes A. Isolation and characterization of a mutant liver aldolase in adult hereditary fructose intolerance. J Clin Invest. 1983; 72:201-213. 50163
    View PubMed
  591. Maton PN, Camilleri M, Griffin GE, Allison DJ, Hodgson HJF, Chadwick VS. Role of hepatic artery embolization in the carcinoid syndrome. Br Med J. 1983; 287:932-934. 50164
  592. Camilleri M, Satti MB, Wood CB. Cystic lymphangioma of the colon. Endoscopic and histologic features. Diseases of the Colon & Rectum. 1982 Nov-Dec; 25(8):813-6. 47228
    View PubMed
  593. Camilleri M, Hemingway AP, Chadwick VS, Blumgart LH, Hodgson HJ, Allison DJ. Embolization of an intrapancreatic aneurysm. Br J Radiol. 1982 Sep; 55(657):685-7. 1312670
    View PubMed
  594. Cox TM, Camilleri M, O'Donnell MW, Chadwick VS. Pseudodominant transmission of fructose intolerance in an adult and three offspring: Heterozygote detection by intestinal biopsy. N Engl J Med. 1982 Aug 26; 307(9):537-40. 47229
    View PubMed
  595. Camilleri M, Murphy R, Chadwick VS. Pharmacological inhibition of chenodeoxycholic acid-induced secretion of fluid and mucus in the rabbit colon. Dig Dis Sci. 1982; 27:865-869. 47226
    View PubMed
  596. Camilleri M, Schafler K, Chadwick VS, Hodgson HJ, Weinbren K. Periportal sinusoidal dilatation, inflammatory bowel disease, and the contraceptive pill. Gastroenterology. 1981 Apr; 80(4):810-5. 44457
    View PubMed
  597. Chadwick VS, Camilleri M. Role of bile acids in the pathogenesis of diarrhea in various diseases. Acta Gastroenterol Belg. 1981; 44:43-48. 44458
    View PubMed
  598. Camilleri M, Cooper BT, Adrian T, Bloom SR, Chadwick VS. Effects of vasoactive intestinal polypeptide and pancreatic polypeptide in the rabbit intestine. Gut. 1981; 22:14-18. 44456
    View PubMed
  599. Camilleri M, Murphy R, Chadwick VS. Dose-related effects of chenodeoxycholic acid in the rabbit colon. Dig Dis Sci. 1980 Jun; 25(6):433-8. 41822
    View PubMed
  600. Camilleri M, Fenech FF. Thrombophlebitis migrans in ulcerative colitis. Postgrad Med J. 1977; 52:762-763. 35160
  601. Camilleri M. Anatomy of the newborn child. Chest-Piece (Malta) 1972 Dec. 26318